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various$ highly$ organized$ tissues,$ each$ being$ indispensable$ for$ the$ optimal$













The$ stability$ required$ for$ embryonic$ development$ is$ provided$ by$ cartilage.$ During$
this$ time,$cartilage$ is$also$responsible$ for$providing$a$template$ for$myogenesis$and$
neurogenesis$to$occur.$Later$in$development$and$in$adult$life,$most$of$the$embryonic$
cartilage$ is$ replaced$ by$ bone,$ in$ a$ process$ denominated$ endochondral$ ossification$
(Horton$et!al.,$1988,$Mackie$et!al.,$2008).$$
In$ order$ for$ endochondral$ ossification$ to$ occur,$ chondrocytes$ must$ progressively$
acquire$ a$ hypertrophic$ phenotype,$ no$ longer$ remaining$ quiescent$ and$ stable.$
Hypertrophy$of$ chondrocytes$ is$ characterized$by$ cell$ enlargement,$ type$X$ collagen$
production$onset$ (Castagnola! et!al.,$1986),$ increased$alkaline$phosphatase$activity,$
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and$ the$ reduction$ of$ type$ II$ collagen$ and$ proteoglycan$ synthesis.$ Moreover,$
protease$ inhibitors,$ which$ prevent$ vascular$ invasion,$ also$ have$ their$ expression$
greatly$ reduced.$ The$ tissue$ becomes$ vascularized,$ and$ the$ hypertrophic$










ends$ of$ ribs,$ hyaline$ cartilage$ is$ the$ most$ abundant$ type$ of$ cartilage.$ It$ provides$
flexible$ support$ in$ the$ nose$ and$ ribs$ and$ can$ sustain$ mechanical$ loading$ during$




Fibrocartilage$ is$ found$ in$ locations$which$are$under$mechanical$ stress$ (i.e.$ tendon,$
ligaments,$ between$ intervertebral$ discs),$ but$ that$ also$ require$ flexibility$ in$ body$













of$mesenchymal$ cells$ (Cancedda! et! al.,$ 1995;$ Cancedda! et! al.,$ 2000;$ Olsen! et! al.,$
2000).$ Precise$ and$ distinct$ patterns$ of$ cell$ differentiation$ and$ arrangement$ are$
required$ for$ the$ establishment$ of$ cartilaginous$ structures.$ Biomechanical$ factors$
(Heegaard!et!al.,$1999),$cellBtoBcell$and$cellBtoBmatrix$ interactions,$and$morphogenB
mediated$ signaling$ (Ganan! et! al.,$ 1996,$ Vogel! et! al.,$ 1996)$ are$ among$ the$ main$
factors$that$guide$and$coordinate$cartilage$formation.$$
During$ development,$ mesenchymal$ precursor$ cells$ migrate$ from$ the$ lateral$
mesoderm$ towards$ the$ presumptive$ skeletogenic$ site$ and$determine$ the$ cartilage$
anlagen$ (Hall$ &$ Miyake,$ 2000).$ $ EpithelialBmesenchymal$ interactions$ result$ in$
mesenchymal$ condensation.$ The$ preBchondrogenic$ condensation$ is$ a$ prerequisite$
for$ the$ establishment$ of$ the$ limb$ skeleton$ (Thorogood$ &$ Hinchliffe,$ 1975)$ and$ is$




development$ (DeLise! et! al.,$ 2000).$ CellBmatrix$ interactions$ are$ also$ key$ to$
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mesenchymal$condensation$(Dessau!et!al.,$1980),$such$as$integrinBmediated$binding$
of$chondrocytes$to$collagen,$which$ is$essential$ for$chondrocyte$survival$ (Cao!et!al.,$
1999;$Lee!et!al.,$2004).$The$overt$differentiation$of$immature$cells$to$fully$committed$
chondrocytes$ is$ observed$ by$ increased$ cell$ proliferation$ and$ by$ upBregulation$ of$
specific$ cartilaginous$ matrix$ components$ (i.e.$ type$ IIα1,$ IX,$ and$ XI$ collagen$ and$
aggrecan).$ To$ maintain$ the$ chondrogenic$ phenotype,$ chondrocytes$ reduce$ their$
proliferative$activity$and$maintain$their$functional$integrity.$$
!





A$ significant$ number$ of$ growth$ factors$ and$ morphogens$ are$ involved$ in$ cartilage$
formation.$ The$ most$ prominent$ factors$ belong$ to$ the$ TGFBβ$ family$ of$ factors$
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The$ FGF$ (fibroblast$ growth$ factor)$ family$ of$ morphogens$ influence$ processes$
correlated$with$cell$division$and$chondrocyte$proliferation$(Olney!et!al.,$2004).$The$
orchestrated$ combination$ of$ defined$ concentrations$ of$ these$ morphogens,$ and$




Cartilage$ is$ essentially$ an$ avascular$ tissue.$ During$ development,$ chondrocytes$ are$
exposed$ to$ a$ low$ oxygen$ environment,$ termed$ hypoxia$ (Brighton$ &$ Heppenstall,$
1971).$$Schipani$and$colleagues$demonstrated$that$hypoxiaBassociated$signals$have$a$
central$ role$ in$ chondrocyte$ differentiation$ and$ cartilage$ development$ (Schipani! et!
al.,$2001).$ $ Importantly,$hypoxia$inducible$factor$1α$(HIFB1α)$has$been$shown$to$be$
expressed$in$the$growth$plate$and$to$have$adaptive$response$to$hypoxia.$It$can$form$
an$active$ transcriptional$complex$and$upBregulate$ target$genes,$ such$as$angiogenic$
factors$ and$ type$ II$ collagen$ (Pfander! et! al.,$ 2003).$ Hence,$ beyond$ conventional$
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Cartilage$ tissue$ is$exposed$ to$stressful$physiological$and$mechanical$ loading$during$
joint$movement.$Specific$arrangement$of$macromolecules$in$the$ECM$is$required$for$







Cartilage$ lesions$ can$ be$ caused$ by$ trauma,$ disease,$ or$ as$ a$ result$ of$ instability$ or$




of$ cartilage$ injury$ according$ to$ the$ size$ of$ tissue$ damage,$ namely$ partial$ and$ full$
thickness$ defects.$ According$ to$ the$ extent$ of$ the$ damage,$ different$ healing$
responses$can$be$verified.$$
In$ partial$ thickness$ defects,$ the$ injured$ cartilage$ is$ capable$ of$ selfBrepair,$ first$
undergoing$necrosis,$followed$by$proliferation$of$chondrocytes$that$are$found$on$the$
lesion$ site.$ In$ the$ short$ run,$ chondrocyte$ aggregates$ temporarily$ produce$ type$ II$
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collagen;$ however,$ in$ the$ long$ run,$ the$newly$ formed$ tissue$ shows$ loss$ of$ hyaline$




by$ this$ type$ of$ defect$ results$ in$ the$ formation$ of$ a$ fibrocartilaginous$ tissue$ in$ the$





tissue$ and$ joint$ degeneration$ (Buckwalter! et! al.,$ 2005).$ Therefore,$ regenerative$
approaches$ that$ are$ able$ of$ restoring$ the$ functional$ properties$ of$ cartilage$ are$ of$




The$ different$ strategies$ to$ treat$ cartilage$ defects$ vary$ from$ more$ conservative$
measures,$ i.e.$ physiotherapy$ and$ drug$ administration$ (corticosteroids,$ hyaluronic$








joint$during$arthroscopy;$debridement$ is$ the$ removal$of$ the$damaged$tissues$ from$
the$joint$(Chang!et!al.,$1993,$Hubbard!et!al.,$1996).$These$procedures,$however,$do$
not$ promote$ cartilage$ repair,$ but$ only$ alleviate$ painful$ joint$ conditions.$ Other$
arthroscopic$ surgical$ procedures,$ such$ as$ drilling,$ abrasion,$ and$microfracture,$ are$
used$ to$ induce$ repair.$ These$ techniques$ take$ advantage$ of$ the$ intrinsic$ repair$
response$ observed$ upon$ penetration$ of$ the$ subchondral$ bone$ in$ full$ thickness$
defects,$relying$upon$the$formation$of$a$blood$clot$and$mesenchymal$progenitor$cell$




As$ common$ standard$ practice$ for$ osteochondral$ defect$ repair,$ autologous$ and$
allogeneic$ tissue$ transplantation$ has$ been$ widely$ in$ clinical$ practice.$ Allogeneic$
material$ is$ of$ cadaveric$ origin$ and$ is$ indicated$ for$ large$ postBtraumatic$ defects$ of$
joints$ (Beaver! et! al.,$ 1992).$ On$ the$ other$ hand,$ autologous$ graft$ implantation$
involves$ the$ removal$ of$ cylindrical$ plugs$ of$ osteochondral$ tissue$ from$ nonBload$
bearing$sites$and$its$ implantation$into$the$defect.$Functional$cartilage$surface$is$reB
established,$but$it$is$limited$due$to$poor$tissue$integration$with$the$adjacent$native$
tissues.$ The$ surgical$ intervention$ also$ damages$ intact$ host$ tissue$ and$ enhances$






In$1987,$Brittberg$and$ colleagues$ introduced$autologous$ chondrocyte$ implantation$
(ACI)$(Brittberg!et!al.,$1994)$as$a$clinically$effective$method$proven$to$restore$tissue$
structure$of$ large$ fullBthickness$ focal$ defects$of$ the$ femoral$ chondyle$ (Peterson! et!
al.,$ 2000).$ The$ technique$ consists$ of$ arthroscopic$ harvesting$ of$ a$ small$ cartilage$
biopsy$ from$ a$ nonBload$ bearing$ area$ and$ subsequent$ transplantation$ of$ in$ vitro$
expanded$ autologous$ chondrocytes.$ ACI$ largely$ improves$ joint$ functionality$ and$
reduces$ the$ pain$ associated$with$ tissue$ damage.$However,$ due$ to$ complexity$ and$
morbidity$associated$with$this$procedure,$ACI$ is$correlated$with$several$ limitations.$
The$ in$vitro$expansion$of$ chondrocytes$ is$necessary$ to$obtain$ sufficient$ amount$of$
cells$for$transplantation$purposes,$but$is$often$associated$with$deBdifferentiation$and$
loss$of$chondrogenic$phenotype.$$
MatrixBinduced$ autologous$ chondrocyte$ implantation$ (MACI)$ derives$ from$ ACI,$ in$
which$ the$ expanded$ cells$ are$ seeded$ directly$ onto$ a$ biomimetic$ scaffold.$ This$
approach$ offers$ potential$ advantages,$ such$ as$ improved$ cell$ retention,$ even$




Tissue$ engineering$ is$ an$ innovative$ field$ of$ research,$which$ has$ emerged$with$ the$
needs$for$threeBdimensional$tissue$repair.$Patient$cells$are$harvested,$expanded,$and$
cultured$under$optimal$conditions$for$subsequent$seeding$onto$scaffolds$prior$to$in$
vivo$ implantation.$ Often,$ bioreactors$ allow$ for$ ideal$ incubation$ and$ culture$
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Figure+ 2.+ A+ combination+ of+ cells,+ scaffolds,+ and+ biological+ factors+ comprise+ the+ Tissue+














this$ problem,$ autologous$ cell$ harvesting$ is$ the$most$ reliable$ cell$ source$ of$ choice.$
Hence,$ autologous$mesenchymal$ stem$ (or$ stromal)$ cells$ and$ chondrocytes$ are$ the$
first$line$of$choice$for$cartilage$tissue$engineering.$$
Undifferentiated,$ multipotent$ mesenchymal$ stem$ or$ stromal$ cells$ (MSC)$ are$ a$
population$ of$ heterogeneous$ cells$ that$ derive$ from$ the$mesoderm$ (Caplan! et! al.,$
1991).$$They$can$be$expanded$in$vitro$and$kept$in$their$undifferentiated$state$when$
maintained$under$appropriate$culture$conditions$(Pittenger!et!al.,$1999,$Reyes!et!al.,$
2001).$ Due$ to$ their$ ease$ of$ harvest,$ proven$ capability$ to$ undergo$ chondrogenesis$
(Pittenger! et! al.,$ 1999),$ and$ multistep$ possibilities$ to$ endure$ controlled$
differentiation$ under$ determined$ circumstances,$ MSC$ are$ a$ favorable$ and$ very$
attractive$ cell$ source$ for$ cartilage$ engineering$ purposes.$ In$ particular,$ MSC$
chondrogenesis$occurs$when$ these$ cells$ are$ cultured$ in$3D$aggregates$or$ “pellets”$
(Johnstone! et! al.,$ 1998;$ Yoo! et! al.,$ 1998)$ or$ cultured$ on$ porous$ polymers$ in$ the$
presence$of$TGFBβ3$(Martin!et!al.,$2001).$Moreover,$ it$has$been$demonstrated$that$
bone$marrowBderived$MSC$migrate$to$a$cartilage$defect$after$microBfracture$of$the$







lose$ their$ typical$differentiated$phenotype$and$acquire$a$ fibroblastBlike$ shape.$ The$
exposure$of$chondrocytes$to$a$variety$of$growth$factors$(e.g.$FGFB2,$TGFBβ1$and/or$
TGFBβ3)$ can$ improve$ the$capacity$of$ chondrocytes$ in$ regaining$ their$differentiated$
state$ (Barbero! et! al.,$ 2003).$ Chondrocytes$ produce$ type$ II$ collagen$ and$ aggrecan$
(Brittberg! et!al.,$2003),$which$ is$ crucial$ for$ECM$reconstitution.$Chondrocytes$have$
limitations$in$supply,$however,$and$must$also$be$expanded$in$order$for$an$adequate$
number$ of$ cells$ to$ be$ available$ for$ repair$ purposes.$ Chondrocytes$ are$ commonly$
harvested$from$the$articular$joint,$ear,$and$nose.$$$
Both$MSC$and$chondrocytes$undergo$hypertrophy,$which$is$detrimental$for$hyaline$
cartilage$ repair,$ as$ it$ conducts$ the$ cells$ to$ endochondral$ ossification,$ which$
ultimately$ remodels$ cartilage$ into$ bone.$ To$maintain$ a$ cartilaginous$ phenotype$ of$




Biomaterials$ (scaffolds)$ mimic$ the$ 3D$ environment$ of$ the$ cartilage$ ECM,$ provide$
structural$ support$ to$ the$ forming$ tissue$ and$ appropriate$ surface$ area$ for$ cellular$
migration,$adhesion,$and$differentiation$(Capito!et!al.,$2003).$The$biomaterial$must$
be$ biodegradable,$ biocompatible,$ have$ a$ defined$ 3D$ structure$ with$ appropriate$
porosity$to$allow$for$cell$ invasion,$ tissue$growth,$nutrient$transport,$and$metabolic$
waste$ removal.$ It$ should$ also$ detain$mechanical$ stability$ for$ in$ vitro$ handling$ and$
subsequent$ surgical$ implantation$ procedures$ and$ provide$ a$ suitable$ surface$
chemistry$ to$allow$ for$absorption$of$proteins$ to$ improve$chondrocyte$attachment,$
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proliferation,$or$differentiation$(Bonzani!et!al.,$2006).$Porous$sponges$are$commonly$
used$ (Putnam! et! al.,$ 1996).$ $Other$ biomaterials,$ such$ as$ collagen$ and$ fibrinBbased$




During$ in$ vitro$ culture$ of$ chondrogenic$ cells,$ specific$ growth$ factors,$ cytokines,$
hormones,$ and$ vitamins$ can$ enhance$ cell$ proliferation,$ migration$ and$
differentiation,$and$in$consequence$allow$for$the$obtainment$of$cells$fully$capable$of$
repairing$cartilage.$
Growth$ factors$ and$ cytokines$ are$ secreted$ molecules$ which,$ when$ bound$ to$
membrane$ receptors,$ can$elicit$ intracellular$ signaling$pathways$ responsible$ for$cell$
adhesion,$proliferation,$and$differentiation,$through$specific$gene$targeting.$
FGF$plays$a$key$role$in$chondrocyte$proliferation$(Kato!et!al.,$1983).$It$also$promotes$
its$ deBdifferentiation$ process$ (Martin! et! al.,$ 2001)$ and$ prevents$ its$ terminal$
differentiation.$TGFBβ,$PDGF,$and$IGFBI$are$also$commonly$used$supplements$known$
for$their$ability$to$induce$chondrogenic$differentiation,$either$by$aggrecan$and$type$II$
collagen$ upBregulation,$ ECM$ synthesis,$ or$ chemoBattractant$ properties$ (Han! et! al.,$
2005,$Holland! et!al.,$2003).$Alongside$with$ the$classical$growth$ factors$mentioned,$










and$ endoderm),$multipotent$ cells$ (ability$ to$ produce$more$ than$ one$ cell$ lineage),$
and$ unipotent$ (can$ differentiate$ only$ into$ a$ single$ cell$ phenotype)$ (Forraz! et! al.,$
2011),$regarding$their$potency$to$produce$one$or$more$lineages.$




termed$ osteogenic$ stem$ cells$ by$ Friedenstein$ (Friedenstein! et! al.,$ 1987).$ In$ 1991,$
Caplan$ defined$ these$ cell$ populations$ as$ mesenchymal$ stem$ cells$ (Caplan! et! al.,$
1991).$ Regarding$ isolation,$ availability,$ and$ clinical$ applications,$ the$most$ relevant$
sources$ for$MSC$are$bone$marrow,$ skin,$placenta,$ and$adipose$ tissue$ (Chen! et!al.,$
2008).$ The$ Mesenchymal$ and$ Tissue$ Stem$ Cell$ Committee$ of$ the$ International$
Society$for$Cellular$Therapy$have$proposed$three$criteria$to$define$MSC:$(1)$isolated$
cells$should$adhere$on$tissue$culture$plates;$(2)$more$than$95%$of$adhering$cells$ in$
the$ culture$ should$ express$ CD105,$ CD73,$ and$ CD90,$ and$ they$ should$ lack$ the$





bones$ and$ in$ the$ intraBtrabecular$ spaces$ of$ spongy$ bones.$ Besides$ containing$
hematopoietic$ precursors,$ the$ bone$marrow$ contains$ different$ nonBhematopoietic$
cells$ including,$ reticular$ and$ endothelial$ cells,$ fibroblasts,$ osteoblasts,$ and$











engineering$ applications.$ Various$ in$ vitro$ studies,$ preclinical$ and,$ more$ recently,$





After$ the$discovery$of$ their$ biological$ property$of$ differentiating$ into$ the$ common$
mesenchymal$lineages,$MSC$were$thought$to$be$responsible$for$the$normal$turnover$
and$maintenance$of$adult$mesenchymal$tissues$(Caplan!et!al.,$2005).$$This$led$to$the$
identification$ of$ MSC$ as$ an$ attractive$ cell$ source$ for$ therapeutic$ applications$ in$
different$fields$of$regenerative$medicine.$$
The$ most$ obvious$ application$ was$ to$ apply$ MSC$ for$ the$ regeneration$ of$
mesenchymal$ tissues,$ such$ as$ bone$ and$ cartilage.$ In$ fact,$ first$ among$ the$ others,$
tissue$engineers$tried$to$exploit$MSC$properties$ for$ the$repair$of$bone$defects$and$
for$the$treatment$of$various$bone$disorders.$Up$to$date,$autologous$bone$graft$still$
represents$ the$ first$ choice$ for$ siteBspecific$ bone$ defect$ repair,$ although$ it$ is$
associated$with$ several$ complications$ such$ as$ donor$ site$morbidity,$ infection,$ and$
loss$of$graft$ function$(Hollinger!et!al.,$1996).$The$combination$of$a$biomaterial$and$
exBvivo$ expanded$ MSC$ is$ thought$ to$ represent$ a$ valid$ alternative$ to$ functionally$












Vertebrates$ have$ very$ complex$ body$ structures$ that$ constantly$ require$ optimal$
delivery$of$nutrients,$signaling$cues,$gases,$and$cells$between$the$various$tissues$of$
their$ bodies.$ In$ order$ for$ this$ to$ happen,$ a$ highly$ organized$ network$ of$ branched$
blood$ vessels$ has$ appeared$ and$ progressed$ throughout$ evolution.$ Indeed,$ blood$




angioblasts$ (vasculogenesis),$which$ is$ largely$ confined$ to$ the$ formation$of$ the$ first$
primitive$ vascular$ structures$ of$ the$ embryo,$ whereas$ angiogenesis$ involves$
enlargement$ of$ the$ vasculature$ through$ sprouting,$ proliferation$ and$ remodeling.$
Angiogenesis,$ unlike$ vasculogenesis,$ is$ the$main$ process$ for$ the$ formation$ of$ the$
vast$ majority$ of$ blood$ vessels$ during$ development,$ tissue$ repair,$ or$ pathological$
processes.$$




tissues,$ e.g.$ cartilage,$ angiogenesis$ is$ thought$ to$ be$ highly$ detrimental,$ since$
cartilage$is$essentially$avascular$and$hypoxic$in$nature.$In$diseased$states$of$cartilage,$
such$ as$ in$ osteoarthritic$ cartilage,$ angiogenesis$ starts$ to$ take$ place$ and$ vessel$





For$ angiogenesis$ to$ occur$ in$ adults,$ local$ ischemia$ is$ required.$ In$ response$ to$ low$
oxygen$ tensions,$ the$ oxygenBsensitive$ hypoxia$ inducible$ factor$ 1α$ (HIF1α)$
upregulates$ many$ factors$ involved$ in$ angiogenesis,$ being$ vascular$ endothelial$
growth$factor$(VEGF)$the$most$important.$It$was$initially$postulated$that$VEGF$might$
play$ an$ important$ role$ in$ regulating$ the$ physiological$ and$ also$ pathological$
angiogenesis.$ VEGF$was$ first$ identified$ in$ 1989$ as$ the$ diffusible$ potent$ inducer$ of$
angiogenesis$ (Leung! et! al.,$ 1989;$ Keck! et! al.,$ 1989).$ Although$ VEGF$ is$ the$ key$
regulator$ of$ angiogenesis,$ other$ factor$ may$ also$ participate$ in$ the$ process;$ being$
angiogenesis$ a$ highly$ complex$ process,$ other$ factors$ must$ also$ coordinate$ the$
events$ in$ order$ to$ promote$ optimal$ blood$ vessel$ formation.$ Among$ other$ factors$
that$participate$in$the$regulation$of$angiogenesis,$angiopoietins,$tumor$growth$factor$
β$ (TGFBβ),$ fibroblast$ growth$ factor$ (FGF),$ placental$ growth$ factor$ (PIGF)$ and$
hepatocyte$ growth$ factor$ (HGF)$ have$ been$ found$ to$ have$ proBangiogenic$ effects$$
(Korpisalo!et!al.,$2010).$$$
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VEGF$ is$ the$ key$ player$ in$ angiogenesis.$ It$ participates$ in$ the$ embryonic$ and$ early$
postnatal$ development$ of$ the$ vascular$ system.$ Besides,$ angiogenesis,$ VEGF$ also$
plays$ an$ important$ role$ in$ other$ physiological$ processes,$ such$ as$ corpus$ luteum$
development$ and$ endochondral$ bone$ formation$ (Ferrara! et! al.,$ 2003).$ VEGF$
dysregulation,$on$the$other$hand,$is$associated$with$various$pathological$conditions.$
VEGF$ also$ plays$ a$ role$ in$ tumor$ angiogenesis$ (Dvorak$et! al.,$ 1995).$ In$ vivo$ studies$
have$ shown$ that$ inhibiting$ VEGF$ activity$ in$ tumors$ results$ in$ suppression$ of$ their$
growth$ in$ animal$ models.$ Several$ clinical$ trials$ using$ small$ molecule$ inhibitors$ or$
humanized$ monoclonal$ antibodies$ (Presta! et! al.,$ 1997;$ Wood! et! al.,$ 2000)$ have$
confirmed$these$findings.$Other$diseases,$such$as$retinopathy$(Adamis!et!al.,$1994)$




Five$ different$ polypeptides$ comprise$ the$ mammalian$ vascular$ endothelial$ growth$
factor$(VEGF)$family,$namely$VEGFBA,$VEGFBB,$VEGFBC,$VEGFBD,$and$placental$growth$
factor$(PIGF)$(Tammela!et!al.,$2005).$These$secreted$glycoproteins$are$homodimeric$
polypeptides$ that$ belong$ to$ the$ PDGF$ family$ of$ growth$ factors.$ In$ other$ nonB








1α$ and$ HIFB1β.$ HIFB1α$ is$ rapidly$ degraded$ under$ normoxic$ conditions$ through$
hydroxylation$ of$ proline$ residues,$ ubiquitination$ and$ targeting$ to$ the$ proteasome.$








Among$ the$mammalian$ VEGFs,$ VEGFBA$ (commonly$ reported$ as$ VEGF)$ is$ the$most$
potent$ and$ bestBcharacterized$ isoform$ of$ VEGF.$ It$ is$ a$ heparinBbinding,$ disulfideB
linked$ dimeric$ glycoprotein,$ which$ plays$ a$ pivotal$ role$ in$ both$ physiological$ and$
pathological$angiogenesis.$Alternative$splicing$provides$ further$ isoforms$of$VEGFBA.$
These$ isoforms$differ$ from$each$other$by$the$presence$or$absence$of$two$domains$




Figure+ 5.+ The+ VEGF+ family+ of+ receptors+ and+ ligands.$ Figure$ adapted$ from$Rahimi,$
2012.$
$
Among$ the$VEGFBA$ isoforms,$ VEGF183,$ VEGF189$ or$ VEGF206$ are$ longer$ and$ have$
strong$ heparinBbinding$ domains$ characteristics,$ therefore$ attaching$ themselves$
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strongly$ to$ the$ ECM.$ Shorter$ isoforms,$ such$ as$ VEGF121$ or$ VEGF145,$ lack$ these$





VEGFR1$ (FltB1),$ VEGFR2$ (FlkB1/KDR),$ and$ VEGFR3$ (Flt4).$ These$ receptors$ are$
expressed$on$the$cell$surface$or$endothelial$cells,$vascular$smooth$muscle$cells,$bone$
marrowBderived$ hematopoietic$ precursors,$ macrophages,$ and$ malignant$ cells$
(Ferrara!et!al.,$2004).$All$VEGFRs$share$the$same$structure$and$are$composed$by$an$
extracellular$domain$organized$in$seven$immunoglobulin$(Ig)Blike$folds,$followed$by$a$
single$ transmembrane$ region,$ a$ juxtaBmembrane$ domain,$ a$ split$ tyrosineBkinase$
domain$interrupted$by$a$kinase$insert$and$a$CBterminal$tail.$$$
VEGFR1$and$VEGFR2$are$ important$ in$blood$vascular$ endothelial$ cell$ proliferation,$
migration,$and$ survival.$Mice$ that$are$homozygous$ for$either$of$ the$ two$ receptors$
die$ during$ early$ development$ due$ to$ defects$ in$ vasculogenesis$ and$ angiogenesis.$





fullBlength,$membraneBbound$ form$ and$ a$ soluble$ form$ (sFlt1),$ considered$ a$ decoy$




regulator$ of$ vascular$ development,$ since$ VEGFR1$ knockout$ animals$ display$




A,$ VEGFBC,$ VEGFBD,$ VEGFBE,$ and$ VEGFBF.$ It$ binds$ VEGFBA$ with$ less$ affinity$ than$
VEGFR1,$ but$ shows$ a$ strong$ kinase$ activity$ that$ results$ in$mitogenic,$ survival$ and$
chemotactic$signals$in$several$cell$types.$VEGFR2$is$expressed$in$higher$copy$number$
than$VEGFR1,$but$has$an$approximately$tenBfold$lower$affinity$for$VEGFBA;$however$
it$ is$ thought$ that$ VEGFR2$ is$ the$ major$ receptor$ transducing$ VEGFBA$ signaling$ in$
endothelial$ cells$ (Ferrara! et! al.,$ 2004).$ VEGFR2$ absence$ is$ lethal:$ embryos$ lacking$
VEGFR2$ die$ and$ fail$ to$ form$ blood$ islands$ and$ to$ complete$ hematopoietic$ and$
endothelial$development.$$
VEGFR3$ binds$ VEGFBC$ and$ VEGFBD$ and$ it$ is$ expressed$ in$ lymphatic$ endothelial$




In$ addition$ to$ the$ VEGF$ receptor$ tyrosine$ kinases,$ two$ nonBkinase$ receptors,$
neuropilinB1$ and$ B2$ (NrpB1,$NrpB2)$ also$ interact$with$members$of$ the$VEGF$ family,$
namely$ VEGFBA$ and$ VEGFBB.$ These$ receptors$ are$ expressed$ not$ only$ on$ vascular$
endothelium$but$also$on$many$types$of$normal$and$tumor$cells.$They$have$long$been$
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coordinated$ delivery$ of$ blood$ components$ (plasma$ and$ leukocytes)$ to$ the$ site$ of$
infection$or$injury.$The$initial$recognition$of$infection$or$injury$is$mediated$by$tissueB
resident$ macrophages$ and$ mast$ cells,$ leading$ to$ the$ production$ of$ a$ variety$ of$
inflammatory$ mediators,$ including$ chemokines,$ cytokines,$ vasoactive$ amines,$
eicosanoids,$ and$ products$ of$ proteolytic$ cascades.$ The$main$ and$most$ immediate$
effect$ of$ these$ mediators$ is$ to$ elicit$ an$ inflammatory$ exudate$ locally:$ plasma$
proteins$ and$ leukocytes$ (mainly$ neutrophils)$ that$ are$ normally$ restricted$ to$ the$
blood$ vessels$ now$ gain$ access,$ through$ the$ postcapillary$ venules,$ to$ the$
extravascular$tissues$at$the$site$of$injury$(or$infection).$The$activated$endothelium$of$
the$blood$vessels$allows$selective$extravasation$of$ leukocytes$while$preventing$ the$
exit$ of$ erythrocytes.$ This$ selectivity$ is$ afforded$ by$ the$ inducible$ ligation$ of$
endothelialBcell$ selectins$ with$ integrins$ and$ chemokine$ receptors$ on$ leukocytes,$
which$occurs$at$the$endothelial$surface$as$well$as$in$the$extravascular$spaces.$
A$ successful$ acute$ inflammatory$ response$ results$ in$ the$ elimination$ of$ the$
inflammatory$agent$(e.g.$tissue$damage)$by$a$resolution$and$repair$phase,$which$ is$
mediated$mainly$by$tissueBresident$and$recruited$macrophages$(Serhan!et!al.,$2005).$
If$ the$ acute$ inflammatory$ response$ fails$ to$ be$ resolved,$ the$ inflammatory$ process$
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persists$ and$acquires$new$characteristics.$ The$neutrophil$ infiltrate$ is$ replaced$with$
macrophages,$ and$ in$ case$ of$ infection$ also$with$ T$ cells.$ If$ the$ combined$ effect$ of$
these$ cells$ is$ still$ insufficient,$ a$ chronic$ inflammatory$ state$ ensues,$ involving$ the$





The$ mononuclear$ phagocytic$ system$ is$ generated$ from$ committed$ hematopoietic$
stem$cells$located$in$the$bone$marrow.$Macrophage$precursors$are$released$into$the$
circulation$ as$monocytes,$ and$within$ a$ few$days$ they$ seed$ tissues$ throughout$ the$
body,$ including$ the$ spleen,$ which$ serves$ as$ a$ storage$ reservoir$ for$ immature$
monocytes$(Geissmann!et!al.,$2010).$When$monocytes$migrate$from$the$circulation$
and$ extravasate$ through$ the$ endothelium,$ they$ differentiate$ into$macrophages$ or$
dendritic$cells.$Thus,$the$primary$role$of$monocytes$is$to$replenish$the$pool$of$tissueB





Circulating$ monocytes$ give$ rise$ to$ a$ variety$ of$ tissueBresident$ macrophages$




the$peripheral$blood,$where$ they$circulate$ for$ several$days$before$entering$ tissues$
and$replenishing$the$tissue$macrophage$populations$(Volkman$&$Gowans,$1965).$$
During$ monocyte$ development,$ myeloid$ progenitor$ cells$ sequentially$ give$ rise$ to$
monoblasts,$ proBmonocytes$ and$ finally$ monocytes,$ which$ are$ released$ from$ the$
bone$marrow$into$the$bloodstream.$Monocytes$migrate$from$the$blood$ into$tissue$
to$replenish$longBlived$tissueBspecific$macrophages$of$the$bone$(osteoclasts),$alveoli,$
central$ nervous$ system$ (microglial$ cells),$ connective$ tissue$ (histiocytes),$
gastrointestinal$ tract,$ liver$ (Kupffer$ cells),$ spleen$ and$ peritoneum$ (Gordon! et! al.,$
2005).$$
The$ morphology$ of$ mature$ monocytes$ in$ the$ peripheral$ circulation$ is$
heterogeneous,$ and$ these$ cells$ constitute$ between$ 5B10%$ of$ peripheral$ blood$
leukocytes$in$humans.$$
In$1939,$Ebert$and$Florey$(Ebert$&$Florey,$1939)$reported$that$monocytes$emigrated$
from$ blood$ vessels$ and$ developed$ into$ macrophages$ in$ the$ tissues.$ ProB
inflammatory,$ metabolic,$ and$ immune$ stimuli$ all$ elicit$ increased$ recruitment$ of$
monocytes$ to$ peripheral$ sites$ (van$ Furth! et! al.,$ 1973),$ where$ differentiation$ into$
macrophages$ and$ dendritic$ cells$ occurs,$ contributing$ to$ host$ defense,$ and$ tissue$
remodeling$and$repair.$$
Peripheral$ blood$monocytes$ show$morphological$ heterogeneity,$ such$ as$ variability$
of$ size,$ granularity$and$nuclear$morphology.$Monocytes$were$ initially$ identified$by$
their$expression$of$large$amounts$of$CD14.$Differential$expression$of$CD14$and$CD16$
allowed$monocytes$ to$ be$ divided$ into$ two$ subsets:$ CD14hiCD16B$ cells,$ which$ are$









It$ was$ shown$ that$ the$ CD14+CD16+monocytes$ expressed$ higher$ amounts$ of$MHC$
class$II$molecules$and$CD32,$and$it$was$suggested$that$these$cells$resemble$mature$
tissue$macrophages$(ZieglerBHeitbrock!et!al.,$1993).$An$additional$monocyte$subset$
that$ is$defined$by$ the$expression$of$CD14,$CD16$and$CD64$has$also$been$ reported$
(GrageBGriebenow! et! al.,$ 2001).$ Compared$ with$ CD14hiCD16B$ (classic)$ monocytes$
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(which$ are$ also$ CD64+),$ these$ CD14+CD16+CD64+$ cells$ have$ a$ similarly$ high$




Macrophages$ are$ strategically$ located$ throughout$ the$ body$ tissues,$ where$ they$
ingest$ and$ process$ foreign$ materials,$ dead$ cells$ and$ debris$ and$ recruit$ additional$
macrophages$in$response$to$inflammatory$signals.$Tissue$macrophages$have$a$broad$
role$ in$ the$maintenance$of$ tissue$homeostasis,$ through$the$clearance$of$senescent$
cells$ and$ the$ remodeling$ and$ repair$ of$ tissues$ after$ inflammation$ (Gordon! et! al.,$
1986,$ 1998).$ Most$ macrophages$ in$ the$ tissues$ of$ an$ adult$ are$ considered$ to$ be$








al.,$ 2011).$ Therefore,$ proBinflammatory$ M1$ macrophage$ responses$ must$ be$
controlled$ to$prevent$extensive$collateral$ tissue$damage$ to$ the$host.$AlternativelyB





the$ activation$ of$ the$ wound$ healing$ response$ and$ for$ tissue$ homeostasis$ to$ be$
restored$ (Sindrilaru! et! al.,$ 2011).$ Recent$ studies$ have$ also$ shown$ that$ M1$
macrophages$ can$ “convert”$ themselves$ into$ an$ M2$ wound$ healing$ phenotype$
(Biswas!et!al.,$2010;$Arnold!et!al.,$2007).$$
ClassicallyBactivated$ macrophages$ (M1)$ arise$ in$ response$ to$ IFNBγ$ (O’Shea! et! al.,$
2008),$which$can$be$produced$during$an$adaptive$immune$response$by$TH1$cells$or$




develop$ in$ response$ to$ innate$ or$ adaptive$ signals.$ Basophils$ and$ mast$ cells$ are$
important$early$sources$of$innate$IL4$(Brandt!et!al.,$2000).$This$early$IL4$production$
rapidly$ converts$ resident$macrophages$ into$M2$macrophages.$ The$M2$ chemokine$
secretion$profile$consists$in$CCL17,$CCL18,$CCL22$and$cytokine$profile$IL10.$$$
M2$ macrophages$ produce$ growth$ factors$ that$ stimulate$ epithelial$ cells$ and$
fibroblasts,$ including$TGFβ1$and$PDGF$ (Barron! et! al.,$ 2011).$M2$macrophages$also$
produce$ matrix$ metalloproteinases$ (MMPs)$ and$ tissue$ inhibitors$ of$
metalloproteinases$(TIMPs)$that$control$ECM$turnover$(Wynn!et!al.,$2008).$They$also$





It$ is$ generally$ believed$ that$ macrophages$ represent$ a$ spectrum$ of$ activated$
phenotypes$ rather$ than$ discrete$ stable$ subpopulations$ (Mosser$ et! al.,$ 2008).$ At$
steady$ state,$ tissue$ macrophages$ have$ intrinsic$ antiBinflammatory$ functions.$ An$
initial$ level$ of$ macrophage$ activation$ occurs$ when$ early$ signals$ trigger$ monocyte$
recruitment$ and$ activation$ or$ when$ IL4$ induces$ in! situ$ macrophage$ proliferation$
(Jenkins$et!al.,$2011).$$
A$key$component$of$the$next$layer$of$the$macrophage$response$is$the$production$of$
antiBinflammatory$ feedback$ mechanisms$ that$ encompass$ cellBintrinsic$ signaling$
feedback$loops$and$cellBextrinsic$mechanisms,$such$as$the$production$of$IL10,$which$
is$ an$ essential$ and$ nonBredundant$ antiBinflammatory$ cytokine.$ The$ final$ layer$ of$






Several$ studies$ indicate$ a$ differentiation$ potential$ of$ monocytes.$ Monocytes$ are$
inherently$ programmed$ to$ differentiate$ into$ macrophages$ or$ dendritic$ cells.$
However,$ the$ differentiation$ course$ of$ monocytes$ can$ be$ altered$ once$ specific$
signals$ are$ provided$ to$ the$ monocytes.$ Many$ studies$ have$ shown$ that$ in$ vitro$
culture$ of$ monocytes$ with$ specific$ media$ conditions$ can$ induce$ monocyte$
differentiation$into$other$cell$types.$
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Figure+ 7.+ Monocyte+ differentiation+ according+ to+ function+ and+ location.+ Figure$
adapted$from$Pollard$et!al.,$2009.$
$
Human$ monocytes$ have$ been$ found$ to$ be$ capable$ of$ differentiating$ into$
mesenchymal$ progenitors$ (Kuwana$ et! al.,$ 2003),$ hepatocyteBlike$ and$ pancreatic$
isletBlike$ cells$ (Ruhnke$ et! al.,$ 2005),$ keratinocyteBlike$ cells$ (Medina$ et! al.,$ 2009),$
endothelial$ cells$ (FernandezBPujol$ et! al.,$ 2000;$ Schmeisser$ et! al.,$ 2001),$ among$
several$other$cell$types.$On$the$other$hand,$claims$have$been$made$concerning$the$
plausibility$ of$ these$ studies,$ regarding$ proper$ cell$ phenotype$ characterization$ and$




























Adamis$ AP,$ Miller$ JW,$ Bernal$ MT,$ D'Amico$ DJ,$ Folkman$ J,$ Yeo$ TK,$ Yeo$ KT$ (1994)$
Increased$ vascular$ endothelial$ growth$ factor$ levels$ in$ the$ vitreous$ of$ eyes$ with$
proliferative$diabetic$retinopathy.$American$journal$of$ophthalmology$118:445B450.$
$




dedifferentiated$ adult$ human$ articular$ chondrocytes.$ Arthritis$ and$ rheumatism$
48:1315B1325.$
$
Beaver$ RJ,$ Mahomed$ M,$ Backstein$ D,$ Davis$ A,$ Zukor$ DJ,$ Gross$ AE$ (1992)$ Fresh$
osteochondral$ allografts$ for$ postBtraumatic$ defects$ in$ the$ knee.$ A$ survivorship$
analysis.$The$Journal$of$bone$and$joint$surgery$British$volume$74:105B110.$
$




stromal$ osteoblasts$ in$ biomimetic$ poly(propylene$ fumarateBcoBethylene$ glycol)B
based$ macroporous$ hydrogels.$ Journal$ of$ biomedical$ materials$ research$ Part$ A$
66:698B706.$
$
Behrens$ P,$ Bitter$ T,$ Kurz$ B,$ Russlies$ M$ (2006)$ MatrixBassociated$ autologous$
chondrocyte$ transplantation/implantation$ (MACT/MACI)BB5Byear$ followBup.$ The$
Knee$13:194B202.$
$
























Cancedda$R,$ Castagnola$ P,$ Cancedda$ FD,$Dozin$B,$Quarto$R$ (2000)$Developmental$
control$ of$ chondrogenesis$ and$ osteogenesis.$ The$ International$ journal$ of$
developmental$biology$44:707B714.$
$
Cao$ L,$ Lee$ V,$ Adams$ ME,$ Kiani$ C,$ Zhang$ Y,$ Hu$ W,$ Yang$ BB$ (1999)$ betaBIntegrinB
collagen$ interaction$reduces$chondrocyte$apoptosis.$Matrix$biology$ :$ journal$of$ the$
International$Society$for$Matrix$Biology$18:343B355.$
$
Capito$ RM,$ Spector$ M$ (2003)$ ScaffoldBbased$ articular$ cartilage$ repair.$ IEEE$









Castagnola$ P,$ Moro$ G,$ DescalziBCancedda$ F,$ Cancedda$ R$ (1986)$ Type$ X$ collagen$
synthesis$ during$ in$ vitro$ development$ of$ chick$ embryo$ tibial$ chondrocytes.$ The$
Journal$of$cell$biology$102:2310B2317.$
$




Chang$ RW,$ Falconer$ J,$ Stulberg$ SD,$ Arnold$ WJ,$ Manheim$ LM,$ Dyer$ AR$ (1993)$ A$




Chen$D,$ Zhao$M,$Mundy$GR$ (2004)$ Bone$morphogenetic$ proteins.$ Growth$ factors$
22:233B241.$
$
Chen$ Y,$ Shao$ JZ,$ Xiang$ LX,$ Dong$ XJ,$ Zhang$ GR$ (2008)$Mesenchymal$ stem$ cells:$ a$
promising$ candidate$ in$ regenerative$ medicine.$ The$ international$ journal$ of$
biochemistry$&$cell$biology$40:815B820.$
$















Keating$ A,$ Prockop$ D,$ Horwitz$ E$ (2006)$ Minimal$ criteria$ for$ defining$ multipotent$




critical$ cytokine$ in$ tumor$ angiogenesis$ and$ a$ potential$ target$ for$ diagnosis$ and$
therapy.$ Journal$ of$ clinical$ oncology$ :$ official$ journal$ of$ the$ American$ Society$ of$
Clinical$Oncology$20:4368B4380.$
$
Dvorak$ HF,$ Brown$ LF,$ Detmar$ M,$ Dvorak$ AM$ (1995)$ Vascular$ permeability$
factor/vascular$ endothelial$ growth$ factor,$ microvascular$ hyperpermeability,$ and$
angiogenesis.$The$American$journal$of$pathology$146:1029B1039.$
$
Ferrara$ N$ (2004)$ Vascular$ endothelial$ growth$ factor:$ basic$ science$ and$ clinical$
progress.$Endocrine$reviews$25:581B611.$
$










Friedenstein$ AJ,$ Chailakhyan$ RK,$ Gerasimov$ UV$ (1987)$ Bone$ marrow$ osteogenic$
stem$ cells:$ in$ vitro$ cultivation$ and$ transplantation$ in$ diffusion$ chambers.$ Cell$ and$
tissue$kinetics$20:263B272.$
$
Ganan$Y,$Macias$D,$DuterqueBCoquillaud$M,$Ros$MA,$Hurle$ JM$ (1996)$Role$of$ TGF$




Getgood$ A,$ Brooks$ R,$ Fortier$ L,$ Rushton$ N$ (2009)$ Articular$ cartilage$ tissue$
engineering:$ today's$ research,$ tomorrow's$ practice?$ The$ Journal$ of$ bone$ and$ joint$
surgery$British$volume$91:565B576.$
$









Transforming$ growth$ factorBbeta1$ (TGFBbeta1)$ regulates$ ATDC5$ chondrogenic$
differentiation$ and$ fibronectin$ isoform$ expression.$ Journal$ of$ cellular$ biochemistry$
95:750B762.$
$


















Hollinger$ J,$Wong$ME$ (1996)$ The$ integrated$processes$of$hard$ tissue$ regeneration$
with$ special$ emphasis$ on$ fracture$ healing.$ Oral$ surgery,$ oral$ medicine,$ oral$
pathology,$oral$radiology,$and$endodontics$82:594B606.$
$
Horton$ WA,$ Machado$ MM$ (1988)$ Extracellular$ matrix$ alterations$ during$
endochondral$ ossification$ in$ humans.$ Journal$ of$ orthopaedic$ research$ :$ official$
publication$of$the$Orthopaedic$Research$Society$6:793B803.$
$
Hubbard$MJ$ (1996)$Articular$debridement$ versus$washout$ for$degeneration$of$ the$
medial$ femoral$ condyle.$ A$ fiveByear$ study.$ The$ Journal$ of$ bone$ and$ joint$ surgery$
British$volume$78:217B219.$
38""
Hunziker$EB$ (1999)$Articular$cartilage$ repair:$are$ the$ intrinsic$biological$ constraints$
undermining$ this$ process$ insuperable?$ Osteoarthritis$ and$ cartilage$ /$ OARS,$
Osteoarthritis$Research$Society$7:15B28.$
$
Johnstone$ B,$ Hering$ TM,$ Caplan$ AI,$ Goldberg$ VM,$ Yoo$ JU$ (1998)$ In$ vitro$
chondrogenesis$ of$ bone$ marrowBderived$ mesenchymal$ progenitor$ cells.$
Experimental$cell$research$238:265B272.$
$






Kato$ Y,$ Hiraki$ Y,$ Inoue$ H,$ Kinoshita$ M,$ Yutani$ Y,$ Suzuki$ F$ (1983)$ Differential$ and$
synergistic$actions$of$somatomedinBlike$growth$factors,$fibroblast$growth$factor$and$
epidermal$ growth$ factor$ in$ rabbit$ costal$ chondrocytes.$ European$ journal$ of$
biochemistry$/$FEBS$129:685B690.$
$
Kearney$ JB,$ Ambler$ CA,$ Monaco$ KA,$ Johnson$ N,$ Rapoport$ RG,$ Bautch$ VL$ (2002)$









therapy.$ Integrative$ biology$ :$ quantitative$ biosciences$ from$ nano$ to$macro$ 2:102B
112.$
$





S,$Kurosaka$M$ (2007)$Treatment$of$a$ fullBthickness$articular$ cartilage$defect$ in$ the$
femoral$ condyle$ of$ an$ athlete$ with$ autologous$ boneBmarrow$ stromal$ cells.$
Osteoarthritis$and$cartilage$/$OARS,$Osteoarthritis$Research$Society$15:226B231.$
$
Kvanta$ A,$ Algvere$ PV,$ Berglin$ L,$ Seregard$ S$ (1996)$ Subfoveal$ fibrovascular$






Lee$ JW,$ Kim$ YH,$ Kim$ SH,$ Han$ SH,$ Hahn$ SB$ (2004)$ Chondrogenic$ differentiation$ of$
mesenchymal$ stem$ cells$ and$ its$ clinical$ applications.$ Yonsei$ medical$ journal$ 45$
Suppl:41B47.$
$
Leung$ DW,$ Cachianes$ G,$ Kuang$ WJ,$ Goeddel$ DV,$ Ferrara$ N$ (1989)$ Vascular$
endothelial$growth$factor$is$a$secreted$angiogenic$mitogen.$Science$246:1306B1309.$
$
Mackie$ EJ,$ Ahmed$ YA,$ Tatarczuch$ L,$ Chen$ KS,$ Mirams$ M$ (2008)$ Endochondral$




of$ human$ marrow$ stromal$ cells$ to$ titanium$ surfaces.$ The$ Journal$ of$ oral$
implantology$29:66B72.$
$
MartelBPelletier$ J,$Di$Battista$ JA,$Lajeunesse$D,$Pelletier$ JP$ (1998)$ IGF/IGFBP$axis$ in$
cartilage$ and$ bone$ in$ osteoarthritis$ pathogenesis.$ Inflammation$ research$ :$ official$
journal$of$the$European$Histamine$Research$Society$$[et$al]$47:90B100.$
$
Martin$ I,$ Suetterlin$ R,$ Baschong$ W,$ Heberer$ M,$ VunjakBNovakovic$ G,$ Freed$ LE$
(2001a)$ Enhanced$ cartilage$ tissue$ engineering$ by$ sequential$ exposure$ of$
chondrocytes$ to$ FGFB2$ during$ 2D$ expansion$ and$ BMPB2$ during$ 3D$ cultivation.$
Journal$of$cellular$biochemistry$83:121B128.$
$
Martin$ I,$ Shastri$ VP,$ Padera$RF,$ Yang$ J,$Mackay$AJ,$ Langer$R,$VunjakBNovakovic$G,$
Freed$LE$(2001b)$Selective$differentiation$of$mammalian$bone$marrow$stromal$cells$














Nagy$ JA,$ Dvorak$ AM,$ Dvorak$ HF$ (2007)$ VEGFBA$ and$ the$ induction$ of$ pathological$
angiogenesis.$Annual$review$of$pathology$2:251B275.$
$








Olsen$BR,$Reginato$AM,$Wang$W$ (2000)$Bone$development.$Annual$ review$of$ cell$
and$developmental$biology$16:191B220.$
$
Patel$ SA,$ Sherman$ L,$ Munoz$ J,$ Rameshwar$ P$ (2008)$ Immunological$ properties$ of$
mesenchymal$ stem$ cells$ and$ clinical$ implications.$ Archivum$ immunologiae$ et$
therapiae$experimentalis$56:1B8.$
$










Phornphutkul$ C,$Wu$ KY,$ Yang$ X,$ Chen$ Q,$ Gruppuso$ PA$ (2004)$ InsulinBlike$ growth$




Simonetti$ DW,$ Craig$ S,$Marshak$ DR$ (1999)$Multilineage$ potential$ of$ adult$ human$
mesenchymal$stem$cells.$Science$284:143B147.$
$






Presta$ LG,$ Chen$ H,$ O'Connor$ SJ,$ Chisholm$ V,$ Meng$ YG,$ Krummen$ L,$ Winkler$ M,$
Ferrara$ N$ (1997)$ Humanization$ of$ an$ antiBvascular$ endothelial$ growth$ factor$
monoclonal$ antibody$ for$ the$ therapy$ of$ solid$ tumors$ and$ other$ disorders.$ Cancer$
research$57:4593B4599.$
$
Putnam$ AJ,$ Mooney$ DJ$ (1996)$ Tissue$ engineering$ using$ synthetic$ extracellular$
matrices.$Nature$medicine$2:824B826.$
$
Quarto$ R,$ Campanile$ G,$ Cancedda$ R,$ Dozin$ B$ (1997)$Modulation$ of$ commitment,$
proliferation,$ and$ differentiation$ of$ chondrogenic$ cells$ in$ defined$ culture$medium.$
Endocrinology$138:4966B4976.$
41""








in$ cartilage:$ HIFB1alpha$ is$ essential$ for$ chondrocyte$ growth$ arrest$ and$ survival.$
Genes$&$development$15:2865B2876.$
$
Staton$ CA,$ Kumar$ I,$ Reed$MW,$ Brown$ NJ$ (2007)$ Neuropilins$ in$ physiological$ and$
pathological$angiogenesis.$The$Journal$of$pathology$212:237B248.$
$
Tammela$ T,$ Enholm$ B,$ Alitalo$ K,$ Paavonen$ K$ (2005)$ The$ biology$ of$ vascular$
endothelial$growth$factors.$Cardiovascular$research$65:550B563.$
$
Thorogood$PV,$Hinchliffe$ JR$ (1975)$An$analysis$of$ the$condensation$process$during$













Wakitani$ S,$ Mitsuoka$ T,$ Nakamura$ N,$ Toritsuka$ Y,$ Nakamura$ Y,$ Horibe$ S$ (2004)$
Autologous$ bone$ marrow$ stromal$ cell$ transplantation$ for$ repair$ of$ fullBthickness$




fabrication$ of$ standardized$ hydroxyapatite$ scaffolds$ with$ a$ defined$ macroB









Yoo$ JU,$Barthel$ TS,$Nishimura$K,$ Solchaga$ L,$Caplan$AI,$Goldberg$VM,$ Johnstone$B$
(1998)$ The$ chondrogenic$ potential$ of$ human$ boneBmarrowBderived$ mesenchymal$








The! overall! goal! of! my! PhD! studies! was! to! analyze! how! the! regulation! of!





properties! and! are! in! direct! contact! with! inflammatory! cells! (monocytes)! in! the!







In! chapter! 1,! we! sought! a! proof! of! principle! to! confirm! that! the! blocking! of!
angiogenesis! does! indeed! improve! cartilage! formation! when! using! geneticallyD
modified!nasal!chondrocytes! (NCs)!or!antiangiogenic!peptides!associated!with!NCs.!
For! this! purpose,! NCs! were! geneticallyDmodified! to! express! mouse! soluble! VEGF!
receptorD2! (sFlkD1)! or! were! associated! with! an! antiangiogenic! peptide! in! order! to!
have! their! chondrogenic! capacity! assessed! in# vitro! and! in# vivo.! Improved! cartilage!
regeneration!could!be!observed!after!in#vivo!implantation!of!NCs!in!an!ectopic!nude!
!44!!
mouse! model.! Whereas! the! antiDangiogenic! approaches! did! not! improve!
chondrogenesis!in#vitro,!frank!chondrogenesis!occured!in#vivo!only!in!the!constructs!
generated! by! NCs! expressing! sFlkD1! or! treated! with! the! peptide.! Blood! vessel!









marrowDderived! MSC! could! augment! their! chondrogenic! potential! in# vivo.! These!
MSC! were! genetically! modified! to! release! sFlkD1,! the! soluble! version! of! VEGF!
receptor! 2! (VEGFR2),! which! acted! as! a! decoy! receptor! and! could! sequester! VEGF!
from! the! immediate! surroundings! of! MSC.! Importantly,! no! external! morphogens!
were! supplemented! in! order! for! MSC! chondrogenic! differentiation! to! occur.!
Moreover,! the! in# vivo! chondrogenic! capacity!of! sFlkD1Dreleasing!MSC!was! assessed!
up!to!12!weeks!by!an!ectopic!nude!mouse!model,!in!which!collagen!sponges!seeded!
with! MSC! were! implanted! subcutaneously.! ! Angiogenesis,! as! analyzed! by! blood!
vessel!invasion,!was!markedly!reduced!in!the!constructs!seeded!with!sFlkD1Dreleasing!









In! chapter! 3,! we! aimed! at! investigating! whether! MSC! can! instruct! monocytes! to!
acquire! traits! of! mesenchymal! progenitors! or! tissue! repair! macrophages! when! in!
direct! or! indirect! contact! with! the! latter.! Thus,! MSC! could! instruct! monocytes! to!
assist!in!the!tissueDrepairing!process.!MSC!and!monocytes!were!cocultured!either!in!
3D! collagen! sponges! or! in! transwells! for! a! period! of! five! consecutive! days.! We!
demonstrated! that! MSC! instruct! monocytes! into! acquiring! a! hybrid! macrophageD
mesenchymal!phenotype,!which!varies!greatly!depending!on!which!kind!of!contact!
with! MSC! the! monocytes! were! exposed! to! (whether! direct! cellDtoDcell! contact! or!
through! the! release! of! soluble! factors! by! MSC).! However,! future! studies! will! be!




























































Autologous! chondrocyte! transplantation! for! cartilage! repair! has! still! unsatisfactory! clinical!
outcomes! because! of! interQdonor! variability! and! poor! cartilage! quality! formation.! ReQ
differentiation! of! monolayerQexpanded! human! chondrocytes! is! indeed! not! easy! in! the!
absence! of! potent! morphogens.! Since! Vascular! Endothelial! Growth! Factor! (VEGF)! plays! a!
master!role!in!angiogenesis!and!in!regulating!cartilage!growth,!we!hypothesized!that!its!sole!
microenvironmental!sequestration!by!VEGF!receptorQ2!(FlkQ1)!could!improve!chondrogenesis!
of! human! nasal! chondrocytes! (NC)! freshly! seeded! on! collagen! scaffolds.! For! this! purpose,!
FlkQ1! was! either! overQexpressed! in! its! soluble! version! by! transduced! NC,! or! mimicked! by!
antiangiogenic! peptides.! Chondrogenesis! of! several! NC! donors! with! differential! potential!




the! control! group.! The!effect!was! even!more!pronounced!when!VEGF!was!blocked! in! low!















articular!chondrocyteQbased! implantation! techniques!are! indeed!associated!with! longQterm!
morbidity! at! the! donor! site! (Dunkin! et! al.,! 2013)! and! to! the! formation! of! nonQ! durable,!
functionally! competent! and! jointQspecific! cartilage! (Pelttari! et! al.,! 2006;! Hunziker! et! al.,!
2009).! High! interQdonor! variability! (Wolf! et! al.,! 2008)! and! loss! of! phenotypic! specificity!
during! in! vitro! expansion! (Dell’Accio! et! al.,! 2001,! Schnabel! et! al.,! 2002)! are! critical! issues!
which! affect! the! chondrocyte! potential! to! form! in! vivo! stable! cartilage! resistant! to! blood!
vessel! invasion! and! mineralization.! Strategies! focused! on! overcoming! such! limitations!
include! supplementation! of! specific! growth! factors! directly! at! the! site! of! implantation! or!
during! expansion! (Francioli! et! al.,! 2007,! Tay! et! al.,! 2004)! and! identification! of! cell!
subpopulation!with!the!highest!chondrogenic!potential! (Dell’Accio!et!al.,!2001,!Schnabel!et!
al.,! 2002,! Hellingman! et! al.,! 2011).! Nevertheless,! the! autologous! chondrocyte!
transplantation,! direct! after! expansion! without! any! cell! preQcommitment,! remains! still! a!
critical!issue.!An!in!vivo!chondroQsupportive!environment!is!crucial!to!induce!chondrogenesis!
and!preserve! the! implant!by!blocking! vessel! and!host! inflammatory! cell! ingrowth,!present!
usually! at! the! implantation! site.! A! biomimetic! tissue! engineering! strategy! aims! at!
recapitulating! some! key! features! of! the! native! tissue! or! mechanisms! that! trigger!
chondrogenesis! during! development.! 3D! preQculture! (Moretti! et! al.,! 2005),! use! of!







(Carlevaro!et!al.,!2000).!Vascular!Endothelial!Growth!Factor! (VEGF)! is!a!crucial! regulator!of!
angiogenesis! (Ferrara!&!Gerber! et! al.,! 2001;! Carmeliet!&! Collen! et! al.,! 2000)! and! skeletal!
growth! (Zelzer! et! al.,! 2002;! Gerber! et! al.,! 1999);! in! particular,! its! downregulation! triggers!
chondrogenesis! and! maintains! chondrocytic! differentiation! and! stability! (Carlevaro! et! al.,!
2000),! and! cartilage! repair! (Street! et! al.,! 2002).! ! Block! of! angiogenesis! by!
microenvironmental! VEGF! sequestration! can! be! achieved! in! different! ways:! either! by!
antiangiogenic!factor!delivery!by!cellQbased!gene!approach!or!by!functionalized!biomaterials.!
Cells! might! be! genetically! modified! to! express! soluble! FltQ1! and! FlkQ1! (which! are! the!
extracellular!cleaved!forms!of!VEGFRQ1!and!VEGFRQ2,!respectively!(Kendall!et!al.,!1996;!Ebos!
et!al.,!2004),!which!can!act!as!decoy!receptors!resulting!in!blocking!angiogenesis.!Kubo!and!
colleagues! showed! how! muscleQderived! stem! cells! overexpressing! sFltQ1! can! support!
cartilage! repair,! but! only! when! combined! with! potent! morphogens! (Kubo! et! al.,! 2009).!!
Alternatively,! block! of! angiogenesis! can! be! achieved!by! scaffolds! functionalized! to! release!
humanized!VEGF!antibody!(Centola!et!al.,!2013)!or!with!synthetic!antiQangiogenic!peptides!
(Foy!et! al.,! 2011)! competing!with!VEGF!binding! to!VEGFRQ2! (Erdag!et! al.,! 2007),! to! inhibit!
endothelial!cell!proliferation!and!sprouting!in!vitro!(Meikle!et!al.,!2011).!!
In! this! study,!we!aimed!at! investigating! the!effects!of!blocking!angiogenesis!on! the! in!vivo!
chondrogenesis! of! nonQpreQcommitted! nasal! chondrocytes! (NC)! from!donors!with! variable!
chondrogenic!potential!upon! implantation! in!a!nonQchondrosupportive!environment.! Since!
culture!in!proQchondrogenic!conditions!is!well!known!to!support!the!further!in!vivo!cartilage!
maturation!and!preservation!(Moretti!et!al.,!2005),!we!also!investigated!whether!preQculture!
alone! can! promote! in! vivo! chondrogenesis! of! constructs! generated! by! low! chondrogenic!




donor! morbidity,! and! capability! to! form! stable! hyaline! cartilage! Q! also! in! response! to!
mechanical!load!Q!when!compared!to!other!cartilage!donor!sites!(Chia!et!al.,!2004;!Tay!et!al.,!
2004;!Barbero!et!al.,!2003;!Rotter!et!al.,!2002).!In!order!to!block!angiogenesis,!we!used!two!
different!methods! to! sequestrate!VEGF! from! the!microenvironment!around! the! implanted!
cells,! one! relying! on! cellQbased! gene! therapy! and! the! other! based! on! the! synthesis! of!
antiangiogenic! peptides,! as! described! above.! Therefore,!mouse!naïve! (not! transduced)!NC!
and!sFlkQ1Qexpressing!NC!were!freshly!seeded!on!a!type!I!collagen!scaffold;!in!addition,!some!
scaffolds! were! preQtreated!with! antiangiogenic! peptides! (also! called! dendron)! in! order! to!
investigate!their!effect!on!naïve!cells.!NC!chondrogenic!and!antiQangiogenic!potential!were!







Human! nasal! septal! cartilage! biopsies! were! harvested! from! different! donors! during!
orthopedic! surgical!procedures! in!accordance! to! the! local!ethical! committee!and! following!
informed! consent.! Nasal! cartilage! was! digested! with! a! 0.15%! type! II! collagenase! solution!
(1mL/100!mg!of!tissue,!Worthington!Biochemical!Corporation,!Lakewood,!USA)!for!22!hours!
at!37°C.!The!samples!were!filtered!(100!μm)!and!the!collagenase!activity!was!hampered!by!
adding! twice! its! original! volume! of! complete!media! (CM),! which! consists! of! high! glucose!




Nasal! chondrocytes! (NC)!were!cultured! in!a!humidified! incubator!at!37°C!and!5%!CO2!at!a!
density! of! 5000! cells/cm2! in! CM! supplemented!with! 5! ng/ml! FGFQ2! (BD! Biosciences),! and!
1ng/mL!of!transforming!growth!factor!β1!(TGFβ1,!R&D!Systems,!Minneapolis,!USA)!in!order!
to!enhance!NC!proliferation!(Tay!et!al.,!2004).!










As! previously! established! by! Barbero! and! colleagues! (Barbero! et! al.,! 2003),! the! 3D! pellet!
culture!model!was!used!for!inducing!NC!towards!chondrogenic!differentiation!using!serumQ
free!medium!(SFM),!which!consists!of!DMEM!(Gibco),!supplemented!with!1%!Hepes!(Gibco),!
1%! penicillinQstreptomycin! solution! (Gibco),! 1%! sodium! pyruvate! (Gibco),! 1%! InsulinQ
transferrinQsodium!selenite!(ITS+1,!SigmaQAldrich,!St.!Louis,!USA),!1%!human!serum!albumin!




and! sFlkQ1! transduced! cells)!were! cultured! for!2!weeks! at! 2%!or!20%!oxygen! tension.! The!
53 
 













A!commercially!available! type! I!collagenQbased!sponge! (UltrafoamTM,!Bard,!Davol! Inc.)!of!3!
mm! thickness!was! punched! into! 6!mm!diameter! disks! and! then! seeded! at! the! density! of!
1.7x106!NC!per! scaffold.! The! constructs!were! cultured!overnight!with!Dulbecco’s!modified!




Type! I! collagen! sponges! (6mmØ,!3Q4!mm!thickness,!UltrafoamTM,!Davol! Inc.)!were!used! to!
















The! percentage! of! population! positive! for! CD8a! in! the! sFlkQ1Qreleasing!NC! and! control!NC!
was! assessed! by! staining! with! a! fluorescein! isothiocyanateQconjugated! antiQrat! CD8a!
antibody! (clone! 53Q6.7;! BD! Biosciences),! using! previously! optimized! staining! conditions! to!
ensure! complete! saturation! of! the! CD8a! molecules! expressed! on! all! cells! in! the!

















Engineered! tissues! cultured! in! vivo! were! digested! with! protease! K! for! 15! hours! at! 56°C!
(Hollander! et! al.,! 1994).! The! glycosaminoglycan! (GAG)! and! DNA! contents! were!measured!
spectrophotometrically! using! dimethylmethylene! blue! (Farndale! et! al.,! 1986)! and! the!






endothelial! cells! growth! supplement,! 50! IU/mL! heparin,! 100! IU/mL! penicillin,! and! 100!
mg/mL!streptomycin)!at!a!density!of!5000!cells/well.! !The!next!day,!GM!was!replaced!with!
assay! medium! (AM)! (consisting! of! M199! with! 5%! FBS,! 10! IU/mL! heparin,! and! 1%!










HUVEC!encapsulation,! along!with! either! sFlkQ1Qexpressing! or! naïve!NC!were!performed!by!
using! a! synthetic! MMPQdegradable! extracellular! matrix! (ECM)! functionalized! with! RGD!




RGD! was! polymerized,! followed! by! 100µL! of! QGel®! without! RGD! and! 100µL! of! sFlkQ1Q
expressing!or!naïve!NC!embedded! in!QGel®!with!RGD.!The!next!day,! growth!medium!was!
replaced!by!assay!medium!supplemented!either!by!0,!0.25,!or!0.75!ng/mL!or! recombinant!





µm! thick)!were! stained! for! SafraninQO! and! for! immunohistochemistry! for! types! I,! II! and! X!
collagen.! Briefly,! for! collagen! immunohistochemistry,! a! preQtreatment! of! the! histological!
sections! was! performed! with! Hyaluronidase! (Sigma)! and! Pronase! (Roche).! The! primary!
antibodies! used! were! mouse! antiQcollagen! I! (MP! Biomedicals,! clone! IQ8H5),! mouse! antiQ











0.1!mol!TEAC! (triethanolamine!containing!acetic!acid).!The!sections!were! incubated! for!30!
min!at!42°C!in!preQhybridization!solution!(consisting!of!20%!SSC!(trisodiumQcitrateQ2Qhydrate,!
pH! 7),! Denhardt’s! solution! 1%! (ficoll,! polyvinylpyrrolidone! and! BSA! solution! in! distilled!
water),! 10%! dextransulfate,! 1%! salmon! sperm! DNA,! 50%! deionized! formamide! and! 18%!
distilled!water).!The!ALU!probe!(Microsynth,!200ng/mL)!was!applied!to!the!slides!and!these!
were! denatured! at! 95°C! for! 3!min,! immediately! cooled,! and! incubated! overnight! at! 42°C.!
Sections!were!equilibrated!with!DIGQ1!buffer!at!RT!for!1!min!(maleic!acid!and!NaCl,!pH!7.5)!
and! blocked! with! 1%! blocking! reagent! for! 15! min! at! RT.! AntiQdigoxygenin! staining! was!
performed!for!1!hour!at!RT!(Roche).!!Successive!washes!with!DIGQ2!(DIGQ1!buffer!with!0.3%!
Tween!20)!and!DIGQ3!(Tris!HCl,!NaCl,!and!MgCl2,!pH!9.5)!were!performed.!The!sections!were!




Histological! sections!were!deparaffinized! for!20!min,!and! then!washed!3x!with!PBS! (5!min!
each! wash).! In! a! humidified! chamber,! the! slides! were! incubated! with! 10%! goat! serum!







488Qconjugated! secondary! antibody! (Invitrogen,! 1:200! dilution! in! PBS/! 0.05%! Tween! 20/!
1.5%!goat!serum)!or!goat!antiQrat!647!secondary!antibody!(Invitrogen,!1:200!dilution!in!PBS/!
0.05%!Tween!20/!1.5%!goat!serum)!and!DAPI!(48x)!for!45!min!in!a!humid!chamber!at!37°C,!





from! the! center! and! the!periphery!of! the! constructs! (average!of! 5! pictures!per! construct)!








The! retroviral! construct! also! contained!a! truncated!–nonQfunctionalQ!mouse!version!of! the!
CD8a! molecule,! to! allow! for! the! cells! to! be! sorted! using! flow! cytometry.! CD8aQonly!
transduced! cell! populations! (as! control)! and! CD8aQsFlkQ1Qtransduced! cells! were! sorted! for!
positivity! in!CD8a!expression,!as! seen! in!Figure!1A.!The! transduction!efficiency! for!NC!was!
86.5±9.2%!(n=3).!The!transduction!process!did!not!impair!the!proliferation!potential!of!NC,!
the!total!cell!doublings!for!naïve,!control!and!sFlkQ1!transduced!NC!was!indeed!similar!in!14!






of! sFlkQ1Qreleasing! NC.! Supernatants! collected! from! monolayer! expansion! of! sFlkQ1Q
expressing!NC!significantly!reduced!human!umbilical!endothelial!cells!(HUVEC)!proliferation!
induced!by!a!concentration!of!VEGF!up!to!10!ng/mL!(Figure!1B).!!
sFlkQ1Qreleasing! NC! also! hindered! the! migration! of! HUVEC! under! two! different!





sFlkQ1Q,! CD8aQ! expressing! (CD8,! control),! naïve! (Naïve)! and! mockQsorted! (Naïve_S)! cell!
populations!were!used!to!investigate!the!effect!of!the!VEGF!blockade!and!the!transduction!
and! sorting! processes! on! the! in! vitro! NC! chondrocytic! reQdifferentiation! capacity! by! using!






affected! by! either! the! transduction! or! sorting! processes.! No! significant! difference! was!





substantial! extracellular! matrix! can! be! observed! (with! slight! variations! among! the!
experimental! groups).! As! for! the! high! chondrogenic! donor,! the! different! oxygen! tensions!
seemed! to! exert! no! effect! on! the! chondrogenic! differentiation! of! naïve! and! CD8! NC.!
Although! a! slight! improvement! in! GAG! formation! was! observed! under! hypoxia! for! sFlkQ1!
pellets! and! under! normoxia! for! sorted! naïve! pellets,! no! statistical! significance! was! found!









in! GAG! deposition! could! be! identified! among! sFlkQ1! and! control! groups! (Figure! 2F,! 2G).!
Overall,! sFlkQ1! did! not! improve! NC! chondrogenesis! in! vitro.! The! in! vitro! scaffoldQbased!




To!verify!whether! sFlkQ1! and! the!dendronized!peptide!WHLPFKC!were! capable!of!blocking!
VEGF! in! vivo,! PECAM! (CD31)! stainings! were! performed! in! order! to! investigate! vessel!





constructs! and! dendronized!WHLPFKC,! CD31Qpositive! vessels! can! be! observed! only! in! the!
host!tissue!surrounding!the!constructs,!which!translates!into!sFlkQ1!and!WHLPFKC!being!able!







IQbased! scaffolds! (Ultrafoam®)! were! implanted! ectopically! in! nude!mice! and! assessed! for!
their! in!vivo!chondrogenic!potential.!Since!it!has!already!been!shown!that!cell!transduction!
and! sorting! did! not! influence! the! chondrogenic! capacity! of! nasal! chondrocytes,! we! used!
naïve!cells!as!control!group.!!
First,!we!sought! to! investigate!whether!a!preliminary!2!weeks!preQculture! in!chondrogenic!
medium!prior!to!the!ectopic!implantation!would!enhance!in!vivo!chondrogenesis!potential!of!




NC! (Supplemental! Figure! 1).! Supplemental! Figure! 2! also! shows! the! in! vivo! survival! of! the!
sFlkQ1! antiangiogenic! approach.! In! this! regard,! sFlkQ1! greatly! enhances!NC! survival! in! vivo,!









donor! is! represented! in!Figures!4,!whereas! the!high!chondrogenic!donor! is! represented! in!
Figure! 5! for! the! geneticallyQmodified! NC! approach.! Figures! 4A! and! 5A! show! the! in! vivo!
safraninQO!comparative!stainings!for!control!NC!and!sFlkQ1QNC!at!4!and!8!week!for!low!and!
high! chondrogenic! donors,! respectively.! Control! NC! were! capable! of! forming! cartilage! in!
vivo,!with!sFlkQ1!constructs!showing!a!clear!improvement!in!GAG!deposition!when!compared!
to!control!constructs,!especially!at!8!weeks!in!vivo.!For!the!low!chondrogenic!donor!control!
NC,!which!were!not! capable!of! forming! cartilage! in! vivo,! the!evidence!of! sFlkQ1! improving!
cartilage! formation! was! striking.! For! the! high! chondrogenic! donor,! sFlkQ1! also! improved!
cartilage!formation,!especially!at!8!weeks!in!vivo.!!
Regarding! collagen! type! II! staining! (Figure! 4B! and! 5B)! no! prominent! differences! could! be!
accounted! for! the! high! chondrogenic! donor.! However,! a! slight! improvement! of! type! II!
collagen! production! could! be! observed! for! the! low! chondrogenic! donor.! For! the! type! X!
collagen,! meanwhile,! no! differences! can! be! seen! between! the! control! and! sFlkQ1! groups!
(Figure!4B!and!5B).!!
Figure! 4C! shows! a! remarkable! increase! of! GAG! production! by! low! chondrogenic! sFlkQ1Q
expressing!NC!both!at!4!and!8!weeks! in!vivo!when!compared!to!control!NC.! In!this!aspect,!
sFlkQ1!greatly!augmented!the!GAG!formation!and!deposition!in!nasal!chondrocytes,!while!it!
did! not! affect! cartilage! remodelling! by!means! of! variances! in! collagen!production.!On! the!
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other! hand,! Figure! 5C! shows! that,! despite! the! fact! that! the! high! chondrogenic! potential!
naïve!NC! already! display! high!GAG! contents! at! both! 4! and! 8!weeks! in! vivo,! sFlkQ1! greatly!
increased! GAG! formation! at! 8! weeks! in! vivo,!which! indicates! once! more! that! preventing!
angiogenesis!can!greatly!enhance!chondrogenesis!of!nasal!chondrocytes!in!vivo.!!
Figure! 6! is! representative! of! a! high! chondrogenic! donor! only! associated! with! the!
















impact! on! the! in! vivo! chondrogenic! potential! of! nonQpreQcommitted! NC! by! significantly!
improving!cartilage!quality!and!enhancing!glycosaminoglycan!(GAG)!deposition!as!compared!
to! controls.! Remarkably,! only!VEGF! sequestration!promoted! in! vivo! cartilage! formation!by!




Based!on!our! results,! it! appears! that! generating!a!permissive!environment! for!NC! is!more!
relevant! than! in! vitro! induction! by! morphogen! supplementation.! Sequestration! of! VEGF!
microenvironmentally! released! by! implanted! human! NC! in! order! to! inhibit! blood! vessel!
ingrowth!within! the! implant! area! reduces! the! risk! of! resorption!of! nonQmature! constructs!
(Centola!et!al.,!2013)!and!supports!chondrogenesis.!Several!studies!showed!indeed!that!antiQ
angiogenic!approach! support! formation!of! stable!cartilage!while!blocking!hypertrophy!and!
endochondral!ossification!(Klinger!et!al.,!2011,!Kubo!et!al.,!2009)!by!either!applying!adenoQ
associated!virus!carrying!chondromodulin!1!complementary!DNA!(Klinger!et!al.,!2011)!or!by!
injecting!mouse!muscleQderived! stem!cells! genetically!modified! to!overexpress! the! soluble!
version! of! sFltQ1! combined!with!morphogenic! factors! (Kubo!et! al.,!2009)! in! knee! cartilage!
lesions.!These!previous!studies!differ!from!ours!by!the!in!vivo!animal!model!adopted!and!by!
the! target! cell! types:! animalQorigin! native! articular! versus! human! deQdifferentiated! nasal!
chondrocytes.! While! Kubo’s! study! indeed! aimed! at! investigating! the! effects! of! several!
growth! factors,! released! by! the! genetically! modified! stem! cells! (which! served! mainly! as!
delivery! system),! on! cartilage! repair,! our! goal! was! to! generate! a! protected! and! chondroQ
permissive!environment!to!allow!sFlkQ1Qexpressing!NC!reQdifferentiation.!However,!as!in!the!
previously! mentioned! studies,! the! enhanced! chondrogenesis! observed! by! adopting! antiQ
angiogenic! strategies! appears! to! be! associated! only! with! paracrine! signaling,! since! the! in!
vitro! chondrogenic! potential! was! not! affected! by! VEGF! as! well! as! other! antiQangiogenic!
factors,! such! as! endostatin! (Jeng! et! al.,! 2010).! Paracrine! VEGF! signaling! is! crucial! for!
angiogenesis! to! take! place,! including! effects! on! EC! proliferation,! survival,! migration,! and!
endothelial!differentiation! (Lee!et!al.,! 2007).! Since!one!of! the! immediate! consequences!of!
inhibition! of! angiogenesis! is! the! generation! of! a! hypoxic! environment,! which! is! a! key!




additional! supplementation! of! a! potent! morphogenic! factor! (TGFβ3),! reduction! of! the!
oxygen!tension!from!20%!to!2%!did!not!result!in!the!deposition!of!cartilaginous!matrix!by!NC!
in! either! experimental! group.! Thus,! hypoxia! alone! was! not! sufficient! to! induce! full!
chondrogenic!differentiation!of!NC! in!vitro,!which!is!in!line!with!Scherer’s!study!(Scherer!et!
al.,!2004),!who!showed!that!while!hypoxia!does!not!prevent!chondrogenesis!differentiation!
in! the! presence! of! chondrogenic! medium! in! vitro,! it! alone! is! not! sufficient! to! induce!
chondrogenic! differentiation! of! human! articular! chondrocytes.! Moreover,! TGβ3!
supplementation!did!not!improve!in!vitro!cartilage!formation!by!NC!when!a!hypoxic!stimulus!
was!applied.!Based!on!our!in!vitro!results!we!can!conclude!that!mechanisms!other!than!the!
sole! combined! supplementation!of!hypoxia! and!morphogen! are! responsible! for! enhancing!
chondrogenesis!in!vivo.!The!lack!of!nutrients!is!also!a!direct!consequence!of!the!absence!of!
blood! vessel! supply;! low! glucose! culture! has! been! shown! to! regulate! the! oxygen! tension!
within! engineered! tissues! (Heywood! et! al.,! 2006)! and! the! chondrogenesis! capacity! of!
chondrocytes!(Heywood!et!al.,!2014).!
The!lack!of!vessels!could!prevent!the!infiltration!of!immune!cells,!such!as!macrophages,!and!
the! availability! of! other!molecules! necessary! for! the! physiological!maintenance! of! the!NC!
phenotype.!Macrophage!infiltration!can!induce!host!reaction!against!the!implant!and!bring!
about!its!premature!resorption.!It!has!been!demonstrated!by!Luo!and!colleagues!(Luo!et!al.,!
2009)! that!a!mild! inflammatory!response!by!the!host! tissue!occurs!when!a!2Qweek! in!vitro!
preQcultured!chondrocyteQbased!construct!is!implanted!in!vivo!compared!to!“no!preQculture!
group”.!Other!studies!have!also!reported!that!in!vitro!preconditioning!can!mitigate!the!postQ




findings,! we! could! clearly! distinguish! macrophage! invasion! within! the! control! groups,!
whereas!the!antiangiogenic!groups!(sFlkQ1!and!dendron)!displayed!a!diminished!macrophage!
invasion,! improving! the! cartilage! quality! and! hampering! its! resorption! and! inflammatory!
reactions! (Centola! et! al.,! 2013).! Moreover,! the! antiangiogenic! approach! was! capable! of!
ameliorating! chondrocyte! survival! when! compared! to! control! groups,! thus! augmenting!
cartilage!maintenance.!
Thus,! vessel! ingrowth! and! subsequent! inflammatory! reaction! that! takes! place! in! cartilage!
engineering! constructs! appears! highly! detrimental! for! the! cartilage! being! formed.! Our!
antiangiogenic! approach! largely! improves! cartilage! reproducibility,! especially! by! low!
chondrogenic! donors,! and! stability! by! hindering! vessel! formation! and! inflammatory! host!
responses! (Centola! et! al.,! 2013).! In! this! way,! our! strategy! allows! the! standardization! of!
cartilage! formation,! circumventing! the! interQdonor! variability! and! the! preQculture! period!




an! ectopic! environment,! which! is! highly! vascularized! and! permissive! but! not! inductive! to!
chondrogenesis!(Dell’Accio!et!al.,!2001;!Scott!et!al.,!2012).!For!this!purpose,!it!was!chosen!as!
to!obtain!the!proof!of!principle!investigation!of!the!effects!of!antiQangiogenesis! in!cartilage!
formation.! However,! further! investigations! in! an! orthotopic! environment,! where! various!
physiological! stimuli! (e.g.!mechanical! loading! and! exposure! of! the!NC! to! the! cartilaginous!
milieu)!can!be!taken!into!account!in!cartilage!formation,!are!of!imperative!importance!in!the!
investigation! of! cartilage! longQterm! stability.! Although! both! the! two! approaches! here!
investigated! resulted! to!efficiently!block!angiogenesis!and!support!chondrogenesis!up! to!8!
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weeks! in! vivo! by! using! the! same! principle! of! sequestrating! VEGF! from! the! implant! cell!
environment,!they!differ!in!the!time!of!efficacy!and!for!their!clinical!translational!potential.!
CellQbased! gene! therapy! indeed! guarantees! a! sustained! release! of! proteins! whereas! the!
scaffold! functionalized! with! the! antiangiogenic! peptide! might! be! limited! in! the! Dendron!
reservoir!capacity.!The!time,!during!which!the!antiQangiogenic!effect!needs!to!be!maintained!
in! order! to! induce! chondrogenesis,! needs! still! to! be! elucidated,! however,! it!will! be! highly!
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above! 80%! (greenQtinted! plot)! and! populations! of! CD8Qpositive! cells! were! purified! after!
sorting! (blueQtinted! line).! Not! stained! cells! were! acquired! as! control! (in! red)! B.! HUVEC!
metabolic!activity!assay!showing!that!sFlkQ1Qcontaining!supernatants!efficiently!blocks!VEGF.!
CD8Qexpressing!NC! supernatants!were!used!as! control.!C.!HUVEC!migration!assay! showing!













naïve,! sFlkQ1!and!dendron!samples! stained!either! in! red! for!PECAM!(CD31),!an!endothelial!
marker,! and! in!blue! for!nuclei! (DAPI),! or! in! green! for! F4/80,! a!macrophage!marker! and! in!





Figure! 4.! In! vivo! chondrogenesis! of! low! potential! nasal! chondrocytes! –! cellHbased! gene!
therapy! approach.! A.! SafraninQO! stainings! for! naïve! and! sFlkQ1Qreleasing! NC! after! 4! or! 8!
weeks!in!vivo.!B.!Types!II!and!X!collagen!stainings!for!naïve!(control)!and!sFlkQ1!NC!at!8!weeks!
in! vivo.!C.! Total! amount! of! GAG! deposited! in! vivo! at! 4! and! 8!weeks! for! naïve! and! sFlkQ1!
expressing!NC.!*!p<!0.01.!Scale!bars!=!50µm.!
!
Figure! 5.! In! vivo! chondrogenesis! of! high! potential! nasal! chondrocytes! –! cellHbased! gene!












































































































































Barbero! A,! Ploegert! S,! Heberer! M,! Martin! I.! Plasticity! of! clonal! populations! of!
dedifferentiated! adult! human! articular! chondrocytes.! Arthritis! Rheum.! 2003!
May;48(5):1315Q25.!
!








Rainer! A,! Marsano! A.! Scaffold.based! delivery! of! a! clinicallyQrelevant! antiQangiogenic! drug!
promotes!the!formation!of!in!vivo!stable!cartilage.!Tissue!Eng!Part!A.!2013;24.!
Chia!SH,!Schumacher!BL,!Klein!TJ,!Thonar!EJ,!Masuda!K,!Sah!RL,!Watson!D.!TissueQengineered!
human! nasal! septal! cartilage! using! the! alginateQrecoveredQchondrocyte! method.!
Laryngoscope.!2004;114(1):38Q45.!
!
Chuang! CY,! Shahin! K,! Lord!MS,!Melrose! J,! Doran! PM,!Whitelock! JM.! The! cartilage!matrix!




human! articular! chondrocytes! to! form! stable! cartilage! in! vivo.! Arthritis! Rheum.! 2001!
Jul;44(7):1608Q19.!
!

























Factors! for! ClinicalQScale! Expansion! of! Human! Articular! Chondrocytes:! Relevance! for!
Automated!Bioreactor!Systems.!Tissue!Engineering!2007;!13(6):1227Q1234.!
Francioli! S,! Cavallo! C,! Grigolo! B,! Martin! I,! Barbero! A.! Engineered! cartilage! maturation!
regulates! cytokine! production! and! interleukinQ1β! response.! Clin! Orthop! Relat! Res.! 2011!
Oct;469(10):2773Q84.!!
Gerber! HP,! Vu! TH,! Ryan! AM,! Kowalski! J,! Werb! Z,! Ferrara! N.! VEGF! couples! hypertrophic!




A.! Generation! of! human! adult! mesenchymal! stromal/stem! cells! expressing! defined!












Heywood!HK,!Nalesso!G,! Lee!DA,!Dell'accio!F.!Culture!expansion! in! lowQglucose!conditions!




damage! to! type! II! collagen! in! osteoarthritic! articular! cartilage! detected! by! a! new!
immunoassay.!J!Clin!Invest.!1994;93(4):1722Q32.!
!








Kendall! RL,! Wang! G,! Thomas! KA.! Identification! of! a! natural! soluble! form! of! the! vascular!
endothelial! growth! factor! receptor,! FLTQ1,! and! its! heterodimerization! with! KDR.! Biochem!
Biophys!Res!Commun.!1996;226(2):324Q8.!
!
Klinger! P,! SurmannQSchmitt! C,! Brem!M,! Swoboda! B,! Distler! JH,! Carl! HD,! von! der!Mark! K,!
Hennig! FF,! Gelse! K.! Chondromodulin! 1! stabilizes! the! chondrocyte! phenotype! and! inhibits!
endochondral! ossification! of! porcine! cartilage! repair! tissue.! Arthritis! Rheum.! 2011!
Sep;63(9):2721Q31.!!
!
Kubo! S,! Cooper! GM,! Matsumoto! T,! Phillippi! JA,! Corsi! KA,! Usas! A,! Li! G,! Fu! FH,! Huard! J.!
Blocking! vascular! endothelial! growth! factor! with! soluble! FltQ1! improves! the! chondrogenic!
potential!of!mouse!skeletal!muscleQderived!stem!cells.!Arthritis!Rheum.!2009;60(1):155Q65.!
Lee!S,!Chen!TT,!Barber!CL,!Jordan!MC,!Murdock!J,!Desai!S,!Ferrara!N,!Nagy!A,!Roos!KP,!IruelaQ
Arispe! ML.! Autocrine! VEGF! signaling! is! required! for! vascular! homeostasis.!
Cell.2007;130(4):691Q703.!
Luo!X,!Zhou!G,!Liu!W,!Zhang!WJ,!Cen!L,!Cui!L,!Cao!Y.! In!vitro!precultivation!alleviates!postQ
implantation! inflammation! and! enhances! development! of! tissue! engineered! tubular!
cartilage.!Biomed!Mat.!2009;4:025006.!
!








potential! of! retroviral! vectors! is! strongly!modulated! by! vector! design! and! integration! site!
selection!in!a!mouse!model!of!HSC!gene!therapy.!J!Clin!Invest!2009;119:964Q75.!
Moretti!M,!Wendt!D,!Dickinson!SC,!Sims!TJ,!Hollander!AP,!Kelly!DJ,!Prendergast!PJ,!Heberer!







Responte! DJ,! Lee! JK,! Hu! JC,! Athanasiou! KA.! BiomechanicsQdriven! chondrogenesis:! from!
embryo!to!adult.!FASEB!J.!2012!Sep;26(9):3614Q24.!!
!
Rotter! N,! Tobias! G,! Lebl! M,! Roy! AK,! Hansen! MC,! Vacanti! CA,! Bonassar! LJ.! AgeQrelated!





Scherer! K,! Schunke! M,! Sellckau! R,! Hassenpflug! J,! Kurz! B.! The! influence! of! oxygen! and!
hydrostatic! pressure! on! articular! chondrocytes! and! adherent! bone! marrow! cells! in! vitro.!
Biorheology.!2004;41:323Q33.!
!







Street! J,! Bao! M,! deGuzman! L,! Bunting! S,! Peale! FV! Jr,! Ferrara! N,! Steinmetz! H,! Hoeffel! J,!
Cleland! JL,! Daugherty! A,! van! Bruggen! N,! Redmond! HP,! Carano! RA,! Filvaroff! EH.! Vascular!






















































1Departments! of! Biomedicine! and! of! Surgery,! University! Hospital! of! Basel,! University! Hospital!
Basel,!Basel,! Switzerland;! 2Institute!of!Pathology,!University!Medical!Center!Mainz,!Germany;! 3!



































Objective.! To! induce! ectopic! chondrogenesis! of! human! bone! marrowVderived! mesenchymal!
stromal!cells!(BMSC)!by!sequestering!VEGF!in!the!implant!area,!in!the!absence!of!any!in!vitro!or!in!
vivo!commitment.!
Methods.! BMSC! were! transduced! by! using! retroviral! constructs! to! express! soluble! VEGF!
receptorV2!(sFlkV1).!The!effect!of!the!transduction!process!and!sFlkV1!release!was!investigated!in!
an! in! vitro! chondrocytic! differentiation! culture! system.! In! vivo! chondrogenic! capacity! of!
genetically!modified!BMSC!was!assessed!by!implantation!for!up!to!12!weeks!in!an!ectopic!nude!
mouse!model,!immediately!after!seeding!in!a!collagen!sponge!scaffold.!
Results.! In! vitro,! neither! the! transduction! process! nor! the! sFlkV1! expression! affected! the!
chondrogenic!potential!of!BMSC.! In!vivo,!blood!vessel!ingrowth!was!significantly!reduced!in!the!












Bone! marrowVderived! mesenchymal! stromal! cells! (BMSC)! have! been! proposed! for! cellVbased!
cartilage! regeneration! due! to! their! capacity! to! differentiate! into! chondrocytes! and! to! their!
availability! also! in! an! autologous! setting.! However,! the! chondrogenic! differentiation! of! BMSC!
typically!requires!the!prolonged!exposure!to!potent!morphogens,!which!may!not!be!available!at!
the!site!of!implantation!(Johnstone!et!al.,!1998).!On!the!other!hand,!the!preVculture!of!BMSC!in!
the! presence! of! chondroinductive! molecules! is! generally! associated! with! the! onset! of! a!
hypertrophic!chondrocyte!phenotype,!leading!to!mineralization,!vessel!ingrowth!and!remodeling!
into!bone!tissue!upon!in!vivo!implantation!(Pelttari!et!al.,!2008;!Scotti!&!Tonnarelli!et!al.,!2010).!!
During! limb! development,! chondrogenesis! of! condensating! mesenchymal! cells! occurs! in! the!
absence!of!vasculature.!Moreover,!the!stability!of!the!chondrocytic!phenotype!at!the!articulating!
surfaces! of! long! bones! as! opposed! to! progression! of! differentiation! towards! endochondral!
ossification! is! associated!with! the!maintenance! of! an! avascular! environment! (Carlevaro!et! al.,!
2000).! Consistent! with! these! observations,! seminal! experiments! of! marrow! stromal! cells!






endochondral! bone! formation,! but! not! by! quiescent! and! proliferating! chondrocytes! at! earlier!




VEGF! has! been! involved! in! the! onset! of! degenerative! changes! of! cartilage! tissue,! such! as!
osteoarthritis!(Murata!et!al.,!2008).!
The! soluble! variants! of! VEGF! receptors,! namely! soluble! FltV1! and! FlkV1! (which! are! the!
extracellular!cleaved!forms!of!VEGFR1!and!VEGFR2,!respectively!(Kendall!et!al.,!1996;!Ebos!et!al.,!
2004)! are! capable! of! acting! as! decoy! receptors,! sequestering! VEGF! from! the! immediate!
chondrocyte!environment.!Kubo!and!colleagues!have!previously!reported!that!articular!cartilage!
repair! by! genetically! modified! skeletal! muscleVderived! stem! cells! in! an! osteochondral! defect!
(Matsumoto! et! al.,! 2009)! or! osteoarthritis! model! (Kubo! et! al.,! 2009)! could! be! improved! by!
overexpression! of! both! soluble! FltV1! and! bone! morphogenic! protein! BMPV4! (a! potent!
chondrogenic!morphogen).!
In! the! present! study,! we! investigated! whether! the! simple! inhibition! of! angiogenesis! by! VEGF!
blockade!could!be!sufficient!to!direct! in!vivo!chondrogenic!differentiation!of!human!BMSC,!in!a!
permissive!environment!and!in!the!absence!of!any!specific!chondrogenic!morphogens.!We!thus!
transduced!BMSC! to! express! sFlkV1,! seeded! them!on! type! I! collagen! scaffolds! (Sabatino!et! al.,!
2012;!Centola!et!al.,!2013),!which!do!not!induce!chondrogenesis!per!se,!and!directly! implanted!














committee! and! following! informed! consent.! BMSC! were! isolated! as! described! by! Horn! and!










Briefly,! cells!were!cultured! in!60Vmm!dishes!and! incubated!with! retroviral! vector! supernatants!
supplemented!with!8µg/ml!polybrene! (SigmaVAldrich,!St.!Louis,!MO)! for!5!minutes!at!37°C!and!
centrifuged! at! 1100g! for! 30! minutes! at! room! temperature! in! the! dishes,! followed! by! fresh!




BMSC! transduced! for! sFlkV1! and! control! cells! were! cultured! in! pellet! systems! as! previously!
described! (Barbero!et!al.,! 2003).!Briefly,! 0.5x106! cells!per!0.5mL!of! serumVfree!medium! (SFM),!
which!consists!of!DMEM!(Gibco),!1%!Hepes!(Gibco),!1%!penicillinVstreptomycin!solution!(Gibco),!
1%! sodium! pyruvate! (Gibco),! 1%! InsulinVtransferrinVsodium! selenite! (ITS+1,! SigmaVAldrich,! St.!
Louis,!USA),!1%!human!serum!albumin!(HSA!100x,! Invitrogen,!Carlsbad,!USA),!0.1!mM!ascorbic!




either! supplemented!with! 10ng/ml! of! TGFβ3! or!without! TGFβ3.! The! pellets! (control! cells! and!
sFlkV1! transduced! cells)! were! cultured! for! 2!weeks! at! 2%! or! 20%! oxygen! tension.! The! culture!




A! type! I! collagen! sponge! (UltrafoamTM,!Bard,!Davol! Inc.,!Warwick,!RI)! of! 4!mm! thickness!was!
punched! into! 6! mm! diameter! disks,! each! of! which! was! statically! seeded! with! 1.7x106! BMSC!
(density!of!1,5x107!cells/cm3)! (Helmrich!et!al.,!2012;!Moretti!et!al.,!2005).!The!constructs!were!
cultured! overnight! with! DMEM! supplemented! with! 10%! FBS! and! 1%! penicillinVstreptomycin!
before!implantation.!!
A! total! of! 4! cellVbased! constructs! was! implanted! subcutaneously! for! each! nude!mouse! (CDV1!
nude/nude,!Charles!River,!Germany).!The!mice!were!sacrificed!with!CO2!at!1,!4,!8!and!12!weeks!
after!the!implantation.!All!animals!were!cared!for!and!processed!according!to!the!guidelines!of!














human! VEGF! production! were! quantified! in! cell! culture! supernatants! using! speciesVspecific!
Quantikine! immunoassay! ELISA! kits! (R&D! Systems,! Abingdon,! UK)! according! to! the!











Total! RNA! of! cells! was! extracted! using! Trizol! (Life! Technologies,! Basel,! Switzerland)! and! the!
standard!singleVstep!acidVphenol!guanidinium!method.!RNA!was!treated!with!DNAseI!using!the!
DNAVfreeTM!Kit! (Ambion,!Applied!Biosystems,!Carlsbad,!CA).! cDNA!was!generated! from!3!µg!of!
RNA! by! using! 500! µg/ml! random!primers! (Catalys! AG,!Wallisellen,! Switzerland)! and! 1µL! of! 50!
U/ml!StratascriptTM!reverse!transcriptase!(Stratagene,!Agilent!Technologies,!Basel,!Switzerland),!
in!the!presence!of!dNTPs.!RealVtime!RTVPCR!reactions!were!performed!and!monitored!using!the!
ABI! Prism! 7700! Sequence! Detection! System! (PerkinV! Elmer/Applied! Biosystems,! Rotkreuz,!
Switzerland),! and! the!gene!expression!data! for!all! tested!genes!were!normalized! to!GAPDH!or!
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18S.! The! primers! used! were! the! following:! GAPDH! (reverse! –! ATGGGGAAGGTGAAGGTCG;!
forward!–!TAAAAGCAGCCCTGGTGACC;!probe!V!CGCCCAATACGACCAAATCCGTTGAC);!18S!(reverse!
–! GCTGGAATTACCGCGGCT;! forward! –! CGGCTACCACATCCAAGGAA;! probe! V!
TGCTGGCACCAGACTTGCCCTC);! type! II! collagen! (reverse! –! GGCAATAGCAGGTTCACGTACA;!
forward! –! CGATAACAGTCTTGCCCCACTT;! probe! –! CCGGTATGTTTCGTGCAGCCATCCT);! type! X!
collagen! (reverse! –! CAAGGCACCATCTCCAGGAA;! forward! –! AAAGGGTATTTGTGGCAGCATATT;!
probe! –! TCCCAGCACGCAGAATCCATCTGA);! RUNXV2! (reverse! –! GCCTTCAAGGTGGTAGCCC;!
forward! –! CGTTACCCGCCATGACAGTA;! probe! –! CCACAGTCCCATCTGGTACCTCTCCG).! Taqman!







µg/ml! streptomycin.! After! one! day! of! culture,! the! growth! medium! was! replaced! by! assay!
medium,!consisting!of!medium199!(Invitrogen,!Basel,!Switzerland)!with!5%!FBS,!10!U/ml!heparin,!
100! U/ml! penicillin! and! 100! µg/ml! streptomycin! (Witzenbichler! et! al.,! 1998),! that! was!
conditioned! by! 6Vhour! incubation! with! either! control! or! sFlkV1! expressing! BMSC! and!
supplemented!with!increasing!levels!of!human!VEGF!(up!to!50!ng/mL).!HUVEC!proliferation!was!
then! assessed! after! three! further! days! of! culture! by! using! [3V(4,5VdimethylthiazolV2Vyl)V5V(3V
carboxymethoxyphenyl)V2V(4Vsulfophenyl)V2HVtetrazolium]!(MTS,!Promega,!Madison,!WI).!
Human!dermal!microvascular!endothelial!cells!(HDMEC)!were!used!in!an!in!vitro!tube!formation!





37°C! by! the! addition! of! double! concentrated! IMDM! medium! (Invitrogen)! and! thrombin! (0.5!
U/ml,! SigmaVAldrich).! Control! or! sFlkV1Vexpressing! BMSC! conditioned! media! (Endothelial! Cell!
Basal!Medium!MV!(PromoCell,!Heidelberg,!Germany)!with!5%!FBS!and!1%!penicillinVstreptomycin!
solution)! were! extracted! after! 48! h.! Human! VEGF! (Biomol,! Hamburg,! Germany)! at! different!
concentrations!(up!to!50!ng/mL)!was!added!to!the!conditioned!media!1!h!before!the!media!were!
used!in!the!tube!formation!assay.!The!formation!of!tubeVlike!structures!by!HDMEC!was!visualized!
48! h! after! embedding! in! collagen/fibrin! gel! via! calceinVAM! (Invitrogen)! staining.! Number! and!
length!of!tubules,!as!well!as!network!characteristics! (number!of!branching!points!and!of! loops,!
defined! as! the! closed! areas! inside! the! tubular! structure)! were! quantified! with! webVbased!
WinTube!Image!Analysis!(Wimasis,!Munich,!Germany).!
Alternatively,! tubeVlike! formation! was! assayed! in! a! direct! coVculture! of! control! or! sFlkV1!
expressing!BMSC!with!HDMEC!(Unger!et!al.,!2002).!1x105!HDMEC!were!seeded!on!gelatin!preV
coated!35!mm!dishes!and!after!24!h!0.3x105!BMSC!were!added.!The!cells!were!coVcultivated!for!
14! days! in! Endothelial! Cell! Basal! Medium! MV! (PromoCell)! with! 15%! FBS,! 1%! penicillinV








thick)! were! stained! for! SafraninVO! and! for! immunohistochemistry! for! types! II! and! X! collagen.!
Briefly,! for! collagen! immunohistochemistry,! a! preVtreatment! of! the! histological! sections! was!
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mouse! IgG/Biotin! (Dako,! 1:200)! was! used.! The! Vectastain! ABC/AP! kit! (Linaris,! Dossenheim,!




Explants!were! fixed! in! 4%! paraformaldehyde! (SigmaVAldrich),! cryoprotected! in! 30%! sucrose! in!
PBS! overnight! and! frozen! in! freezing! isopentane! (SigmaVAldrich)! after! embedding! in! OCT.!
Cryosections! (10!μm!thick)!were! incubated!with! the!primary!antibodies!pan!human!antiVnuclei!
(BD!Pharmingen,!Franklin!Lakes,!NJ)!and!with!a!secondary!antibody!labelled!with!Alexa!Fluor!546!
(Invitrogen/Life! Technologies,! Carlsbad,! CA).! DAPI! was! used! as! nuclear! staining.! Fluorescence!




Immunohistochemical! processing! was! applied! as! previously! described! (Ghanaati! et! al.,! 2011).!
Briefly,! an! initial!quenching!of!endogenous!peroxidase!activity!using!3%!H2O2! in!demineralized!
water! was! performed! after! deparaffinizing! and! rehydrating! the! tissue! sections.! HeatVinduced!
epitope!retrieval!was!then!applied!using!citrate!buffer!with!a!pH!of!6.0!for!mouseVspecific!CD31!








using! oneVway! analysis! of! variance! (ANOVA)! with! Bonferroni! correction.! Differences! were!






The!efficiency!of! BMSC! transduction! to! express!CD8a! alone!or! in! combination!with! sFlkV1!was!
82±7%!and!89±3%,!respectively.!Genetically!modified!BMSC!released!1.37±0.14!ng/106!cells/day!
of!mouse! sFlkV1.! The! transduction! process! did! not! impair! the! proliferation! potential! of! BMSC,!
despite!a!slight!reduction! in!the!doubling!rate! in!monolayer!culture!when!compared!to!control!
BMSC!(total!cell!doublings!of!5.6±0.5,!4.5±0.8,!3.9±0.2! for!naïve,!control!and!sFlkV1! transduced!
BMSC,! respectively,! in!14!days,!data!are!presented!as!mean!±SEM,!n=2),! consistently!with!our!
previous! findings! (Helmrich! et! al.,! 2012).! The! transduction! process! also! did! not! affect! the!
chondrocytic!reVdifferentiation!capacity!of!BMSC!in!transwell!culture.! In!fact,!the!GAG!per!DNA!
ratio! of! the! tissues! formed! by! CD8V! or! CD8a/sFlkV1Vexpressing! BMSC! (18.8±9.1! and! 27.6±8.9,!
respectively)!was! similar! or! even!higher! than! that! by!naïve! cells! (14.5±1.8).! Based!on! these! in!
vitro!results,!most!of!the!subsequent!analyses!were!performed!using!only!naïve!cells!as!control.!
Secreted!sFlkV1!was!biologically!active,!as!shown!by!its!ability!to!impair! in!vitro!angiogenesis!by!




substantially! reduced! endothelial! cells’! organization! into! tubular! structures,! as! shown! by! the!
decreased! tube! number! and! length,! as! well! as! the! maturation! of! capillaryVlike! networks,! as!
shown!by! the! lower!branching!points! and!number!of! loops! (Figures! 1! IVL).! The! inhibition!of! in!






We! then! tested!whether! VEGF! blockade!would! influence! BMSC! chondrogenesis! in! vitro.! Since!
hypoxia!is!known!to!enhance!VEGF!expression!(Liu!et!al.,!1995)!and!has!been!postulated!to!play!a!
role! during! chondrogenesis! (Malladi!et! al.,! 2007;! Kanichai!et! al.,! 2008),! the! experiments!were!
performed!at!different!oxygen!tensions!and!chondrogenesis!was!assessed!by!SafraninVO!staining!
and! biochemical! analysis! of! GAG! deposition! (Supplementary! Figure! 1).! No! differences! in!
chondrogenesis! could! be! observed! among! the! sFlkV1Vexpressing! and! control! BMSC! under! the!
different! oxygen! tensions.! Cartilaginous! tissues! formed! in! the! presence! of! TGFβV3! at! either!
oxygen!tension!by!control!and!sFlkV1!BMSC!were!morphologically!similar!(Supplementary!Figure!
1!AVD),!with!no!differences!in!the!amount!of!GAG!(Supplementary!Figure!1E).!












Since!sFlkV1! is!not! responsible! for!promoting!chondrogenesis! in!vitro,!we!sought! to! investigate!
whether! other! factors!would! contribute! to! cartilage! formation! in! vitro.! The! pellet! culture!was!
repeated!using!only!control!BMSC!with!and!without!the!supplementation!of!TGFβ3.!When!in!the!
presence! of! TGFβ3,! no!major! differences! in! BMSC! chondrogenesis! were! observed! among! the!
different!oxygen!tensions.!No!significant!differences!were!detected!histologically!or!at!the!mRNA!
level!(Figure!2!AVE).!However,!once!TGFβ3!was!removed!from!the!pellet!culture,!chondrogenesis!
only! occurred! under! hypoxia,! which! can! be! observed! by! SafraninVO! (Figure! 2F)! and! type! II!
collagen! (Figure! 2H).! Furthermore,! type! X! and! IHH,! typically! overexpressed! in! hypertrophic!




Control! or! sFlkV1Vexpressing! BMSC! were! loaded! into! collagen! sponges! and! immediately!
implanted!subcutaneously! in!nude!mice!to!assess!their!vascularization!potential.!Quantification!
of! vessel! ingrowth! was! performed! on! CD31! stained! cross! sections! on! the! total! area! of! the!
implant.! Constructs! based! on! control! BMSC! displayed! an! ingrowth! of! vessels! already! after! 1!
week,!up! to! the! center!of! the! implant! (Figure!3!AVD).! Instead,!no! vessel! infiltration!within! the!
implant! area! was! observed! in! the! center! of! sFlkV1! constructs! up! to! 12! weeks,! such! that! the!
angiogenic! process! was! confined! at! the! periphery! of! the! implant! (Figure! 3! EVH).! Explants!
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generated! by! control! or! sFlkV1! expressing! BMSC! displayed! a! clear! difference! in! macroscopic!
vascularization!at!12!weeks!(Figure!3I).!Control!constructs!appeared!smaller!and!vascularized!as!
compared! to! the! sFlkV1Vexpressing! BMSCVbased! implants,! which! had! a! white! cartilageVlike!
appearance.! Quantitative! analysis! further! indicated! a! significantly! higher! vessel! density! in! the!





and! in!any!of! the!5!donors! investigated! in!this!study!(Figures!4A,!4C,!4E).!Remarkably,! instead,!






hyaline! cartilage! marker,! was! expressed! at! undetectable! level! in! expanded! BMSC! (data! not!
shown)!and!was!210–fold!higher!expressed!in!the!BMSC!expressing!sFlkV1!as!compared!to!control!
naïve!cells! (Figure!4G).!On!the!contrary,!the!expression!of!osteogenic! (Runx2)!and!hypertrophy!
(type! X! collagen)! markers! was! markedly! reduced! by! at! least! 10Vfold! in! sFlkV1! constructs! as!
compared!to!control!BMSC.!




all! time!points! (Figure! 5!GVH).! In! the! control! group! a! loose! connective! tissue!was! formed! and!
neither!type!II!nor!type!X!collagen!could!be!detected!by!immunostaining!(Figure!5!AVD).!










efficient! inhibition! of! angiogenesis,! could! reproducibly! induce! in! vivo! chondrogenesis! by!





and!adulthood! is! the!avascular!nature,!our! findings!provide! the!unprecedented!proof! that! the!
sole! regulation! of! angiogenesis,! without! the! delivery! of! any! additional! morphogens,! may! be!
sufficient! for! inducing! mesenchymal! progenitors! into! full! chondrogenic! differentiation.! The!
effects!of! sFlkV1!on!cartilage! formation!by!BMSC!were! investigated! in!an!ectopic!environment,!





osteochondral! defect! (Kubo! et! al.,! 2003)! or! osteoarthritis! (Matsumoto! et! al.,! 2003)! models,!
unless! a! potent! chondrogenic! morphogen! (BMPV4)! was! additionally! delivered.! The! apparent!
discrepancy! may! imply! (i)! the! yet! uncontrolled! complexity! of! biochemical! or! biomechanical!
regulatory! signals! at! an! orthotopic! joint! environment! and/or! (ii)! a! fundamental! biological!
difference! between! the! two! species! and! classes! of! progenitors,! with! BMSC! –! as! opposed! to!
MDSC!V!being!physiologically!responsible!for!cartilage!formation!(Yoo!et!al.,!1998).!




process! of! endochondral! ossification! (Scotti! &! Tonnarelli! et! al.,! 2010).! Mechanistically,! these!
findings! could! be! explained! by! the! indirect! effect! of! inhibition! of! angiogenesis,! or! by! a! direct!
autocrine!regulation!by!sFlkV1,!as!VEGF!is!expressed!by!human!BMSC!(Kaigler!et!al.,!2003),!and!
immature!(Maes!et!al.,!2004)!as!well!as!hypertrophic!(Carlevaro!et!al.,!2000)!chondrocytes.!
Our! in! vitro! experiments! indicate! that!blocking!VEGF!by! sFlkV1!expression!did!not! regulate! the!
chondrogenic! capacity! of! BMSC,! consistent! with! a! previous! report! using!muscleVderived! stem!
cells!releasing!sFltV1!(Kubo!et!al.,!2009).!Since!one!of!the!immediate!consequences!of!inhibition!
of! angiogenesis! is! the! generation!of! a! hypoxic! environment,! and!hypoxia! is! a! key! regulator! of!
chondrogenesis!during!limb!development!(Araldi!et!al.,!2010),!we!next!investigated!the!effects!of!
hypoxia! in!promoting! in!vitro!chondrogenesis.!Strikingly,! in!the!absence!of!TGFβ3,!reduction!of!






Interestingly,!when!differentiated! in! the! hypoxic! environment! in! the! absence! of! TGFβ3,! BMSC!
seem! to! acquire! an! articular! chondrocyteVlike! phenotype! as! shown! by! the! downregulation! of!
collagen!type!X!and!Indian!Hedgehog.!!
Thus,! we! have! shown! that! hypoxia! alone! is! capable! of! (i)! triggering! full! chondrogenic!
differentiation!of!BMSC! in!vitro!(Robins!et!al.,!2005,!Kanichai!et!al.,!2008),!(ii)!inducing!a!BMSCV
derived! hyaline! chondrogenic! phenotype! in! vitro,! and! (iii)! maintaining! a! longVterm! stable!
phenotype!of!the!neoVengineered!cartilage!in!vivo!upon!VEGF!blockade.!!
Furthermore,!the!effect!of!inhibition!of!angiogenesis!on!BMSC!could!have!also!been!mediated!by!
a! reduced!delivery!of! specific!nutrients.! For!example,! limited!availability!of!glucose!could!have!
forced! its! reduced! consumption,!which!physiologically! parallels! chondrocytic! differentiation!by!
mesenchymal!progenitors!(Pattappa!et!al.,!2011).!Alternatively,!our!findings!could!be!explained!
by!the!fact!that!BMSC!would!not!be!exposed!to!possible!inhibitors!of!chondrogenesis!present!in!
serum! or! released! by! platelets! (Zhu! et! al.,! 2013;! Boilard! et! al.,! 2010),! as! well! as! to! proV




phagocytic! function.! Similarly,! the! absence! of! remodeling! of! the! resulting! cartilage! into! bone!
tissue! would! likely! be! mediated! by! the! impairment! to! monocytic/osteoclastic! cells,! whose!
recruitment,! differentiation! and! activity! is! known! to! be! dependent! on! VEGF! (Aldridge! et! al.,!
2005;!Niida!et!al.,!2005).!!
In! order! to! develop! towards! a! clinical! relevance! the! here! described! strategy! to! induce! BMSC!







Alternatively,! the! therapeutic! approach! could! be! implemented! by! a! scaffoldVbased! delivery! of!
humanized!monoclonal! VEGF! antibodies,! as! recently! described! for! the! enhanced! formation! of!
cartilage!by!human!nasal!chondrocytes!(Centola!et!al.,!2013).!Thus,!the!current!study!establishes!
that!two!of!the!main!obstacles!towards!BMSCVbased!cartilage!repair,!namely!the!efficiency!and!
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1!expressing!BMSC! (D7F)! supplemented!with!0! (A,D),!10! (B,E)!or!50! (C,F)!ng/mL!of!VEGF.!Total!
tube!number! (I),! length! (J),! branching!points! (K)! and! loops! (L)!were!quantified!with! the! image!
analysis! (10! images!per! sample!were!analyzed,! the!data!are!presented!as!mean!+!SEM,!n=3V4;!
*p<0.05,! **p<0.01).! Immunofluorescence! staining! for! CD31! in! green! showing! the! capillaryVlike!
structure! formation! in! the!direct!coVculture!of!either!control! (G)!or!sFlkV1Vexpressing! (H)!BMSC!
with! HDMEC.! Scale! bars=300! µm.! HUVEC! proliferation! assay! (M)! performed! by! using!
supernatants!collected!by!either!control,!namely!naïve,!or!sFlkV1!expressing!BMSC.!
!
Figure! 3.! ! In! vivo! blocking! of! angiogenesis.! Immunohistochemistry! for! mouse! CD31.!
Representative!images!at!20x!magnification!of!the!implants!generated!by!naive!(A7D)!and!sFlkV1!
expressing! (E7H)! BMSC! at! 1! (A,! E),! 4! (B,! F),! 8! (C,! G)! or! 12! weeks! (D,! H).! Representative!
macroscopic!picture!of!the!explants!of!engineered!tissue!generated!by!naïve!(on!the!left)!or!sFlkV
1!expressing!(on!the!right)!BMSC!after!12!weeks! in!vivo!(I).!Vessel!density!quantified!within!the!
total! area! of! the! implant! generated! by! control! (naïve)! or! sFlkV1V! expressing! BMSC! at! different!
time! points! by! histomorphometric! analysis! (J).! Arrow! heads! indicate! the! blood! vessels.! Scale!
bar=100!µm.!
!
Figure! 4.! ! In! vivo! chondrogenesis.! Histological! staining! of! SafraninVO! for! glycosaminoglycans!
(GAG)!of!engineered!tissue!generated!by!naive!(A,!C,!E)!or!sFlkV1Vexpressing!(B,!D,!F)!BMSC!after!
1!(A,!B),!4!(C,!D)!or!12!(E,!F)!weeks!in!vivo.!Analysis!at!mRNA!level!of!types!II!and!X!collagen,!and!
RunxV2! genes! of! engineered! constructs! generated! by! naïve! (control)! or! sFlkV1! expressing! cells!












with!*).! Empty! and! full! arrow!heads! indicate!human! (both!positive! for!human!nuclei! antibody!
and!DAPI)!and!mice!(stained!only!with!DAPI)!cells,!respectively.!Scale!bar!=!50!µm.!
!
Supplementary! figure! 1.! ! In! vitro! chondrogenesis.! Histological! staining! of! SafraninVO! for!
glycosaminoglycans! (GAG)!of! cartilaginous! tissue!engineered!by! control! (naïve)! (A,!C)! or! sFlkV1!
expressing!(B,!D)!BMSC!at!either!20!(A,!B)!or!2!(C,!D)!%!of!oxygen.!Graph!displaying!the!ratio!of!
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Damaged! articular! cartilage! derived! from! traumatic! lesion! has! limited! potential! for! repair!
due!to!its!avascular!nature!and!loss!of!cellular!matrix,!and!to!the!self7renewal!limitations!of!
chondrocytes,! which! includes! reduced! cell! migration! and! proliferation.! The! currently!
established! method! for! clinical! cartilage! repair,! autologous! chondrocyte! transplantation,!
displays! poor! binding! to! adjacent! intact! articular! cartilage! and! lacks! restoration! of!
subchondral!bone,! commonly! leading! to! the! formation!of! fibrocartilage,!which! is! less! rigid!
when!compared!to!hyaline!cartilage.!Moreover,!host!response!to!damaged!tissue,!primarily!
with! neutrophil! and! macrophage! infiltration! to! the! damaged! site,! prevents! or! impairs!
complete!tissue!restoration.!
Monocytes!are!cells!that!respond!to!inflammatory!cues!in!the!initial!phases!of!inflammation.!
Monocytes!originate! in! the!bone!marrow!and!are! later! released! into!the!peripheral!blood,!
where! they! replenish! several! tissue!macrophage! populations! (Volkman!&! Gowans,! 1965).!
The!differentiation!of!monocytes!into!macrophages!and!other!cells!(e.g.!dendritic!cells)!is!a!
physiological!process!that!contributes!to!host!defense,!tissue!remodeling,!and!repair.!!
Macrophages! have! an! important! role! in! maintaining! tissue! homeostasis,! for! they! are!
competent! phagocytic! cells! responsible! for! clearance! of! debris,! dead! cells,! and! foreign!
organisms,! as! well! as! remodeling! and! repairing! tissue! after! the! inflammatory! process!
(Gordon,! 1998).! Among! the! different! classes! of! macrophages,! the! classically7activated!
macrophages! (also! denominated! M1! macrophages)! are! responsible! for! immune! defense.!
This! response!must!be! thoroughly! controlled! in!order! to!avoid! collateral! tissue!damage! to!
the! host! in! the! advent! of! severe! and! unrestrained! inflammation.! On! the! other! hand,!
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macrophages! are! not! always! pro7inflammatory! cells! with! detrimental! effects! on! tissue!
regeneration;!they!also!play!an!important!role!in!inflammation!resolution!and!tissue!repair,!
namely! through! its! “alternatively7activated! macrophages”,! also! generally! called! M2!
phenotype.!!
It!has!been!proposed!through!several!studies!that!monocytes!are!capable!of!differentiating!
into! other! cellular! types,! with! the! delivery! of! specific! cues! in! order! to! alter! its! default!
programming!into!becoming!macrophages!or!dendritic!cells.!Kuwana!and!collegues!(Kuwana!
et! al.,! 2003)! proposed! that! circulating! CD14+! monocytes! could! serve! as! a! source! for!
mesenchymal!progenitors.!Peripheral!blood!mononuclear!cells!(PBMC),!after!being!cultured!
with! fetal!bovine!serum!(FBS)!and! fibronectin,!were!capable!of!differentiating! into!distinct!
mesenchymal! cell! lineages.! Interestingly,! these! cells! displayed! not! entirely! a! monocytic!
phenotype,! also! displaying! CD34! and! type! I! collagen,! indicative! of! mixed! features! of!





vitro! in! response! to!a!combination!of!pro7angiogenic! factors! (Fernandez7Pujol!et!al.,!2000;!
Schmeisser! et! al.,! 2001).! Other! studies! have! revealed! that!multipotent! cells! of!monocytic!
origin!were! capable!of! improving!heart! function! (Dresske!et!al.,! 2006),!differentiating! into!
cardiomyocyte7like!cells!(Kodama!et!al.,!2005),!hepatocyte7like!and!pancreatic!islet7like!cells!
(Ruhnke! et! al.,! 2005),! and! into! keratinocyte7like! cells! (Medina! et! al.,! 2009).! In! all! of! the!




it! is!not!currently!known!if!monocytes!are!capable!of!differentiating! into!different! lineages!
without!having!the!supplementation!of!external!cues.!!
Intriguingly,! some!studies!contest! the!capability!of!monocytes! to!differentiate! into!cells!of!
other! lineages,!due!to!the!fact!of!proper!characterization!of!the!cellular!phenotype.!Rohde!
and!colleagues!(Rohde!et!al.,!2006),!for!instance,!claimed!that!myeloid!and!monocytic!cells!
share! several! properties! with! endothelial! cells,! which! makes! it! difficult! to! affirm! that!





at! investigating!whether!MSC! that! are! recruited! to! the! cartilage! injury! site! are! capable! of!
instructing!monocytes!to!acquire!traits!of!tissue!repairing!macrophages!and/or!stromal!cells!
with!a!mesenchymal!phenotype.!For!this!purpose,!we!cocultured!monocytes!with!MSC!in!3D!
collagen!sponges! (direct!cell7to7cell! contact)!or! in! transwell! systems! (soluble! factor! release!









(MSC)!were! isolated! as! described! by!Horn! and! colleagues! (Horn! et! al.,! 2008).! Fresh! bone!
119 
 
marrow!were! plated! at! a! density! of! 105! nucleated! cells/cm2! and! cultured! in! high! glucose!
DMEM!(Gibco,!Carlsbad,!CA)!containing!4.5!mg/ml!D7Glucose,!0.1!mM!nonessential!amino!
acids,! 1! mM! sodium! pyruvate,! 100! mM! HEPES! buffer,! 100! U/ml! penicillin,! 100! µg/ml!




plating!with!previously!described! retroviral! vectors,!which!consisted!of!a!mouse! truncated!
CD8a!gene!fused!to!an!Internal!Ribosomal!Entry!Site!(IRES)!(Misteli!et!al.,!2010).!Cells!were!
transduced!according!to!a!recently!described!high7efficiency!protocol!(Helmrich!et!al.,!2012).!
Cells! were! incubated! with! retroviral! vector! supernatants! supplemented! with! 8µg/ml!
polybrene! (Sigma7Aldrich,! St.! Louis,!MO)! for! 5!minutes! at! 37°C! in! 607mm!dishes! and! then!
centrifuged!at!1100g! for!30!minutes!at! room!temperature! in! the!dishes,! followed!by! fresh!
medium!replacement.!Transductions!were!repeated!twice!a!day!for!a!total!of!6!rounds.!Cells!
were!expanded!for!two!passages!and!re7plated!at!a!density!of!104!cells/cm2.!
Monocytes! were! isolated! from! buffy! coats! provided! by! healthy! donors! (routine! blood!
donations!at!the!Basel!Cantonal!Hospital)!using!the!traditional!Ficoll™!gradient!assay.!Briefly,!
the! blood! was! diluted! 1:2! in! PBS! and! then! 1:3! in! Ficoll™! (Sigma7Aldrich).! The! blood!
suspension!was!then!centrifuged!at!2000!rpm!for!30!minutes.!After!centrifugation,!the!white!
blood! cell! layer! was! removed! and! diluted! 1:3! in! PBS,! washed! for! 15! min! at! 1500! rpm,!
resuspended!in!cold!MACS!buffer!(PBS!with!1%!EDTA!and!1%FBS)!and!washed!again!for!10!
min!at!1200!rpm,!then!finally!placed!into!a!Falcon!tube!with!5!mL!of!cold!MACS!buffer.!The!
white! cell! population!was! filtered!with! a! 40uM!nylon! cell! strainer! (BD! 352340),! and! then!






(complete!medium).! The! cells!were! incubated!with! the!beads!on! ice! for! 20!min.! The! cells!
were!then!washed!at!1500!rpm!for!10!min!to!obtain!a!white!blood!cell!pellet.!The!pellet!was!












(Ultrafoam®,! Davol,! Inc.)! of! 4mm! in! diameter! in! a! 1:1! ratio! (0.2M! cells! of! each! type)! in!








were! incubated! with! trypsin! (0.05%,! Life! Technologies)! for! 10! min! at! 37°C! in! an! orbital!








anti7mouse! CD8a! (clone! 53–6.7;! BD! Biosciences)! as! previously! described! (Helmrich! et! al.,!
2012)!by!using!a!FACS!ARIA!sorter!(Becton!Dickinson,!Allschwil,!Switzerland)!the!remaining!




Phenotypes! of! monocytes! co7cultured! with! MSC! were! analyzed! upon! staining! with! the!
following!antibodies:!allophycocyanin!(APC)7labeled!anti7CD90!(clone!5E10,!BD559869),!anti7
CD106! (clone! STA,! Biolegend! 305809),! anti7CD14! (clone! M5E2,! BD561708),! anti7CD206!
(clone!19.2,!BD561763),!phycoerythrin!(PE)7labeled!anti7CD73!(clone!AD2,!BD561014),!anti7
CD105!(clone!266,!BD560839),!anti7CD166!(clone!3A6,!Biolegend!343903),!anti7CD11b!(clone!
ICRF44,! BD555388),! anti7CD163! (clone! GHI/61,! BD556018),! anti7nestin! (clone! 25/NESTIN,!
BD561230),! fluorescein7isothiocyanate! (FITC)7labeled! anti7CD68! (clone! Y1/82A,! BD562117),!









the!manufacturer’s! protocol.! ! cDNA!was! generated! from!3!µg!of! RNA!by!using! 500!µg/ml!
random!primers! (Catalys!AG,!Wallisellen,! Switzerland)!and!1!µL!of!50!U/ml! StratascriptTM!
reverse!transcriptase!(Stratagene,!Agilent!Technologies,!Basel,!Switzerland),!in!the!presence!
of! dNTPs.! cDNA! samples! were! amplified! and! analyzed! by! real7time! RT7PCR! reactions! and!
monitored! using! the! ABI! Prism! 7700! Sequence! Detection! System! (Perkin7! Elmer/Applied!
Biosystems,!Rotkreuz,!Switzerland).! !Taqman!Assays!on!Demand!(Applied!Biosystems)!were!
used! to! evaluate! the! expression! of! several! genes,! all! purchased! from!Applied! Biosystems:!
IL1β! (Hs01555410_m1),! IL6! (Hs00985639_m1),! IL10! (Hs00961622_m1),! IL12!
(Hs01073447_m1),! MCAM! (Hs00174838_m1),! SDF71! (also! known! as! CXCL12,!
Hs00171022_m1),! TGFβ1! (Hs00998133_m1),! TNFα! (Hs01113624_g1),! and! Sox9!
(Hs00165814_m1).! Type! II! collagen,! on! the! other! hand,! had! its! primers! and! probe!
synthesized!by!Microsynth!(reverse!primer!–!GGCAATAGCAGGTTCACGTACA;!forward!primer!
–!CGATAACAGTCTTGCCCCACTT;!probe!–!CCGGTATGTTTCGTGCAGCCATCCT).!Gene!expression!










For! the! chondrogenic! differentiation,! serum7free! DMEM! (Gibco,! 4.5%! glucose,! with! NEAA!
and!without!L7glutamine!and!sodium!pyruvate)!containing!1%!sodium!pyruvate!(Gibco),!1%!
HEPES! (Gibco),! 1%! penicillin7streptomycin! solution! (Gibco),! 1%! ITS! +! 3! (Sigma7Aldrich,! St.!
Louis,! USA)! and! 1%! human! serum! albumin! (HSA! 100x,! Invitrogen,! Carlsbad,! USA)! was!













contact! (transwell! system).! After! the! 5! day! culture! period,! monocytes! were! analyzed! for!
their!change!of!phenotype!through!FACS!and!quantitative!PCR!analyses.!!












cultured! monocytes! with! MSC! when! analyzed! for! the! acquisition! or! loss! of!
monocyte/macrophage!markers.!Naïve!monocytes!are!used!as!control!cells!throughout!our!
study,! since! mono7cultured! monocytes! did! not! survive! the! 57day! culture! period.! Naïve!
monocytes!were!positive! for!CD14! (99.5%)!and!CD11b! (98%).!CD14! is! a!monocyte7specific!




When!monocytes!were! co7cultured!with!MSC! in! transwells,! their! phenotype!were! slightly!
different!than!naïve!monocytes.!Transwell!monocytes!were!positive!for!CD14!(97%),!CD11b!
(88.2%),! and! negative! for! CD68.! This! implies! that! transwell! monocytes! had! very! little!
differences! in! macrophage! activation7related! marker! expression.! Meanwhile,! 1.5%! of! the!
transwell!monocytes! started! to! express! CD163;! impressively,! 88%! of! the! latter! cells! were!
positive!for!CD206,!indicating!a!clear!transition!to!an!M27like!phenotype.!!
When! analyzing! 3D7cultured! monocytes,! only! 30%! of! the! cells! remained! CD147positive.!
95.7%!of!the!cells!were!positive!for!CD11b,!and!only!5%!were!positive!for!CD68.!Despite!the!
high! positivity! for! CD11b,! these! monocytes! are! transitioning! away! from! the! monocytic7
macrophage! lineage;! since! these!cells!were!negative! for!CD163!and!only!2%!of! these!cells!
were! positive! for! CD206,! we! cannot! conclude! that! these! cells! are! acquiring! an! M27like!
phenotype.!












level!of!expression! for! this!marker.!The!difference!between!naïve!and! transwell!monocyte!
expression!was!not!statistically!significant.!The!fact!that!3D!monocytes!did!not!express!IL10!
corroborates!the!lack!of!an!M27like!phenotype!by!the!latter!cells.!On!the!other!hand,!TGFβ1!








although! TNFα! expression! by! transwell! monocytes! is! statistically! lower! than! by! naïve!
monocytes! (107fold!difference).! IL1β! is! expressed!by! all! groups,! but! 3D!monocytes!have! a!
statistically! higher! expression! compared! to! all! other! cell! types,! including! naïve!monocytes!
(107fold!difference)!and!MSC!(1007fold!difference).! IL1β!is!normally!expressed!by!many!cell!
types! (including! MSC)! and! plays! and! important! role! in! modulating! MSC! differentiation!
(Mumme!et!al.,!2012).!On!the!other!hand,!naïve!monocytes!do!not!express!IL6!or!IL12!unless!
stimulated.!MSC!and!transwell!monocytes!express!IL6!and!IL12,!although!MSC!express!much!
higher! amounts! of! these! proinflammatory! cytokines! when! compared! to! unstimulated!
transwell!monocytes.!3D!monocytes,!however,!only!express!IL6,!and!at!comparable!levels!to!
MSC.! Taken! together,! this! data! indicates! that! transwell! monocytes! display! an! M27like!






capable! of! acquiring! a! mesenchymal7like! phenotype! after! direct! or! indirect! contact! with!
MSC.!!
In!Figure!3,!we!show!the!FACS!analyses!results!for!naïve,!transwell7cultured,!and!3D7cultured!




CD166,! nestin,! and! stro71! as!MSC!markers.! In! our! analyses,! CD44,! CD90,! and! CD166! have!




CD166.! Interestingly,! 3D! monocytes! had! a! steep! reduction! in! CD44! expression! when!
compared!with!naïve!monocytes!(only!66%!positive!cells)!and!in!CD166!expression!(only!51%!
positive! cells).! Meanwhile,! transwell! monocytes! also! displayed! a! reduction! in! CD90! and!
CD166!expression!when!compared!with!naïve!monocytes!(20%!and!48.7%,!respectively).!
Figure! 3! also! shows! the! relative! CD105! expression! in! all! three! groups.! Interestingly,! naïve!
monocytes! are! 39%! positive! for! CD105;! transwell! monocytes! show! a! drastic! increase! in!
CD105!expression!(84.1%!positive!cells),!whereas!3D!monocytes!actually!show!a!decrease!in!
CD105!expression!(3.5%!positive!cells).!Naïve!monocytes!were!also!9.5%!positive!for!CD29.!
Transwell!monocytes! show! a! reduction! in! CD29! expression! (only! 1.5%! positive! for! CD29),!
while! 3D!monocytes!have!almost!double! the!CD29!expression!when! compared!with!naïve!
monocytes!(22%!positive!cells).!!
In!our!experimental! setup,! the!most! reliable!MSC!phenotypic!markers!were!CD73,!CD106,!
nestin,!and!stro71.! !Naïve!monocytes!were!virtually!negative! for! these!markers! (being!only!
0.05%!for!nestin!and!5%!positive!for!CD106).!Nestin!expression,!however,!remained!negative!

















As! for! CD106,! transwell! monocytes! had! a! significant! increase! in! its! expression! when!
compared!with!naïve!monocytes!(30%!positive!cells),!and!a!whopping!82%!positivity!for!3D!
monocytes.!!
In! Figure! 4,! we! analyzed! the! gene! expression! levels! of! MCAM! (melanoma! cell! adhesion!
molecule,!CD146,!or!cell!surface!glycoprotein!MUC18)!and!SDF71!(stromal!cell7derived!factor!
1,!also!known!as!C7X7C!motif!chemokine!12!or!CXCL12),!which!are!mesenchymal!markers.!!
SDF71! was! expressed! by! naïve! monocytes,! but! it! is! expressed! 100! times! more! by! MSC.!
Transwell! monocytes! displayed! very! little! expression! of! SDF71! (even! lower! than! naïve!
monocytes).!3D!monocytes,!on!the!other!hand,!expressed!highly!significant! levels! if!SDF71,!
even! higher! than! MSC! expression.! Importantly,! only! MSC! and! 3D! monocytes! expressed!
MCAM.!Taken!together,!the!FACS!and!quantitative!data!analyses!indicate!that!3D!monocytes!
display!several!MSC!traits!and!may!acquire!a!mesenchymal!phenotype!through!direct!cell7to7




Since! the! prerogative! of! functional! MSC! is! their! ability! to! differentiate! into! cells! of! the!
mesenchymal! lineage! (e.g.! chondrocytes),!we! investigated!whether! transwell7cultured!and!
3D7cultured! monocytes! could! undergo! chondrogenic! differentiation! in! vitro! in! a! similar!
manner!as!MSC.!!!
Figure! 5! shows! naïve,! transwell,! and! 3D! monocytes! after! their! 37week! post7coculture!














57day! coculture! period! with! MSC.! ! Sox9! and! type! II! collagen! expression! of! transwell! and! 3D!
monocytes!in!chondrogenic!pellet!culture!after!MSC!coculture.!
!
During! the! chondrogenic! differentiation! period,! no! pellet! formation! could! be! observed,!







3D! monocytes! after! they! underwent! in! vitro! chondrogenic! differentiation.! SOX9! is! not!
expressed!by!either!transwell!or!3D!monocytes;!it!is!only!expressed!by!control!MSC.!On!the!
other! hand,! the! expression! of! type! II! collagen! by! transwell! and! 3D! monocytes! are! very!






The! objective! of! this! study! was! to! investigate! whether! mesenchymal! stromal! cells! (MSC)!
could! instruct! monocytes! into! acquiring! an! M27like! macrophage! phenotype! and/or!
mesenchymal! traits,! with! the! intent! to! benefit! from! monocytes! that! infiltrate! cartilage!
lesions! and! could! eventually! help! MSC! in! the! regeneration! of! the! tissue.! Here,! we!
demonstrate!that!monocytes!are!capable!of!expressing!some!M2/MSC!characteristics!upon!














role! in! their! immunosuppressive! effects,! such! as! hepatocyte! growth! factor! (HGF),!
prostaglandin!E2! (PGE2),!TGFβ1,! indoleamine!2,37dioxygenase! (IDO),!and! IL10! (Aggarwal!&!
Pittenger,! 2005,! Beyth! et! al.,! 2005).! A! few! other! studies! have! suggested! that! contact7
dependent!mechanisms!may! also! be! implicated! in! the! immunosuppressive! effects! of!MSC!
(Krampera!et!al.,!2003;!Augello!et!al.,!2005).!!
Due! to! their! intrinsic! organic! functions,! immune! cells! are! capable! of! adapting! to! different!
environments! upon! different! immune! response! mechanisms.! Not! only! do! immune! cells!
execute!various!inflammatory!and!host!defense!mechanisms,!they!are!active!participants!in!




proliferative! rate! and! self7renewal! properties.! Moreover,! these! cells! were! capable! of!




Several! reports!have! claimed! that!monocytes! (CD14+! cells)!were! capable!of!differentiating!
into! progenitor/stem! cell7like! cells! or!mature! cells! of! other! lineages.! Zhao! and! colleagues!
135 
 
have! identified!adult!pluripotent!stem!cells! that!originated! from!human!monocytes.!These!
cells! displayed! fibroblastic! appearance,! were! capable! of! fast! expansion! when! exposed! to!
macrophage!colony7stimulating! factor! (MCSF)!and,!being!CD14+CD34+CD45+,!also!displayed!








These! cells,! termed!MOMPs! (monocyte7derived!mesenchymal! progenitor),! were! obtained!
once!peripheral!blood!mononuclear!cells!(PBMC)!were!cultured!in!vitro!on!fibronectin!in!the!
presence! of! FBS.! MOMPs! displayed! a! fibroblastic! morphology,! along! with! a! unique!
CD14+CD34+CD45+type!I!collagen+!molecular!signature.!These!cells!showed!mixed!molecular!
characteristics! of!monocytes,!mesenchymal,! and! endothelial! cells.!MOMPs!were! found! to!
derive! from! CD14+! monocytes;! the! latter! required! fibronectin! binding! and! exposure! to!
soluble!factors!from!peripheral!blood!CD147!cells!in!order!to!give!rise!to!MOMPs.!!
In! our! studies,! human! MSC! were! cocultured! with! monocytes! in! both! transwell! and! 3D!
culture!system!for!5!consecutive!days.!We!hypothesized!that,!through!the!release!of!soluble!
factors!or!through!cell7to7cell!contact,!MSC!would!be!able!to!instruct!monocytes!to!sustain!a!




Our!results! indicate! that,!while! transwell!monocytes! (monocytes!cocultured!with!MSC! in!a!
transwell! system)! displayed! a! mixed! M17M2! phenotype,! 3D! monocytes! (monocytes!
cocultured!with!MSC!in!3D!collagen!sponges)!started!to!transition!away!from!the!monocytic!
lineage,! though! still! presenting! a! few! macrophage! characteristics.! Transwell! monocytes!
exhibited! a! very! high! CD206! expression! (M2)! associated! with! high! TNFα,! IL6,! and! IL12!




macrophages! support! the! growth! of!MSC,! such! as! IL10,! TGFβ1,! and! VEGF! (Freytes! et! al.,!
2013).! Moreover,! when! human! MSC! were! cocultured! with! purified! subpopulations! of!
immune!cells,!they!altered!the!cytokine!secretion!profile!of!dendritic!cells,!NK!cells,!and!TH1!
and! TH2! cells,! inducing! a! more! anti7inflammatory! phenotype! of! these! cells! (Aggarwal! &!
Pittenger,!2005);!this!could!be!an!indicator!that!M2!phenotype!can!indeed!be!sustained!by!
monocytes!in!direct!or!indirect!contact!with!MSC.!!
3D! monocytes,! on! the! other! hand,! suffered! substantial! loss! of! CD14! and! lack! of! specific!
macrophage!cytokine!expression.!These!cells,!however,!did!have!high!IL1β!expression,!even!
when!compared!with!the!expression!of!IL1β!by!MSC.!IL1β!is!expressed!in!high!levels!by!MSC,!
where! it!plays!a! role! in!MSC!recruitment!and! in!modulating! the!differentiation!capacity!of!
these!cells!(Mohanty!et!al.,!2010).!!
When!the!capacity!of!monocytes!to!acquire!a!mesenchymal!phenotype!was!tested,!several!





defined!by! the! co7expression!of!multiple!markers.! In!our! experiments,!many!markers! that!
are! commonly! expressed! by! MSC! were! also! expressed! by! monocytes,! proving! to! be!
unreliable! for! mesenchymal! phenotype! testing.! For! our! experimental! purposes,! CD73,!
CD106,!nestin,!and!stro71!were!the!most!reliable!mesenchymal!markers,!since!they!were!not!
expressed!by!monocytes.!Whereas!nestin!remained!negative!in!all!conditions,!CD73,!CD106,!
and! stro71! were! significantly! expressed! by! 3D! monocytes.! For! transwell! monocytes,!
however,! only! CD106! had! a! significant! expression,! but! still! much! lower! than! its! 3D!
counterpart.! On! the! cytokine! level,! only! 3D! monocytes! expressed! significant! levels! of!
mesenchymal! cytokines,! namely!MCAM! and! SDF71.! This! indicates! that! 3D!monocytes! are!
more!prone!to!acquiring!a!mesenchymal!phenotype,!and!could!therefore!directly!participate!
in! tissue!regeneration,!directly!contributing! to! the!repair! functions!of!MSC.!As!shown!with!








In! this! study,! we! investigated! the! ability! of! MSC! in! instructing! monocytes! to! acquire! a!
macrophage!and/or!mesenchymal!phenotype.!Our!results!indicate!that,!while!monocytes!do!
not! actively! contribute! to! cartilage! tissue! formation! as! do! MSC,! they! could! actively!
participate! in! supporting! and! assisting! MSC! with! their! functions,! either! by! acquiring! a!
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formation!by! two!cell! sources! that!are! currently!used! for!articular! cartilage! repair,!
namely!nasal! chondrocytes! (NC)! and!mesenchymal! stromal! cells! (MSC).!Moreover,!
we! analyzed! if! MSC,! while! being! recruited! to! repair! a! cartilaginous! lesion! and!
detaining! immunomodulatory! properties,! could! induce! monocytes! (inflammatory!
cells!infiltrating!the!cartilage!lesion!site)!to!acquire!traits!of!tissue!repair!cells.!Hence,!
MSC! could! significantly! benefit! from! their! ability! to! control! angiogenesis! and!
inflammatory!events!during!cartilage!repair!processes.!
Chapter& 1! showed! that! two! distinct! methods! for! blocking! VEGF,! namely! sFlkH1!
overexpression! and! an! antiHangiogenic! peptide! (WHLPFKC)! were! both! capable! of!
greatly! inhibiting! angiogenesis! and! promoting! chondrogenesis! in# vivo! by! nonH
preculturedHNC!primaries.!High!and!low!primaries!were!tested;!the!terms!“high”!and!
“low”!refer!to!the!chondrogenic!capacity!of!these!NC.!Both!types!of!primaries!were!
capable! of! undergoing! chondrogenesis! in# vivo! when! expressing! sFlkH1! or! when!
associated! with! the! antiHangiogenic! peptide.! ! Importantly,! whereas! control! “high”!
chondrogenic! NC! could! undergo! chondrogenesis! in# vivo,! both! antiHangiogenic!
approaches! greatly! enhanced! cartilage! formation! in! these!donors.! Importantly,! for!
the! “low”! chondrogenic! NC! primaries,! only! the! ones! overexpressing! sFlkH1! were!




Chapter& 2! showed! that! VEGF! signaling! blockade! by! sFlkH1! effectively! inhibited!
angiogenesis! and! induced! in# vivo! chondrogenesis! by! MSC,! without! the!
supplementation! of! additional! chondrocytic! morphogens.! It! has! also! been! shown!
that!hypoxia! is!effectively!a!trigger!for!MSC!chondrogenesis!to!take!place,!and!that!
VEGF! blockade! by! sFlkH1! in# vivo! promotes! the! necessary! hypoxic! environment! for!
chondrogenesis! to! occur! in! an! ectopic! mouse! model.! sFlkH1! overexpression! also!
enhanced! MSC! cell! survival! in# vivo! up! to! 12! weeks.! Furthermore,! the! cartilage!
formed!by! sFlkH1Hoverexpressing!MSC!preserved!a! stable! chondrogenic!phenotype,!
as!it!did!not!exhibit!traits!of!cartilage!remodeling!and!endochondral!ossification.!!
Chapter& 3! showed! that! monocytes! that! were! cocultured! with! MSC! in! transwells!
acquired! some! M2! traits,! and! monocytes! cocultured! with! MSC! in! 3D! collagen!
scaffolds!were!more!prone!to!acquiring!a!mesenchymal!phenotype.!This!could!imply!
that!monocytes! infiltrating! into! the! cartilage! lesion! site! could!be! instructed!by! the!
resident!MSC!to!become!tissue!repair!cells!thus!actively!participating!in!the!healing!
of! the! cartilage! defect.! This! phenotype! change! induction! could! be! done! either! by!





The! selfHrepair! capacity! of! articular! chondrocytes! is! very! limited.! Being! an! aneural!
and! avascular! tissue,! cartilage! regeneration! is! a! complex! process! with! currently!





cultured! chondrocytes! into! a! chondral! defect)! and! MatrixHInduced! Autologous!
Chondrocyte! Implantation! (MACI,! a! porcine! type! I/type! III! collagen! bilayer! seeded!
with! chondrocytes)! have! become! the! established! treatment! for! symptomatic!
osteochondral!defects.!These!procedures!are!designed!to!heal!cartilage!damage!by!
filling!the!cartilage!defect!with!cells!capable!of!repairing!the!cartilaginous!tissue.!!
The! studies! performed! in! chapters! 1! and! 2! show! a! remarkable! advantage! for!
potential!therapeutic!MSC!and!NC!cartilage!engineering.!Both!studies!focus!solely!on!
angiogenesis! as! a! key! regulator! of! cartilage! formation,! without! the! need! of!
additional! growth! factors! to! trigger! chondrogenesis! or! in# vitro! preculture.! These!
clear! advantages! make! these! cartilage! repair! approaches! highly! attractive! for! a!
clinical!application!setting.!With!these!approaches,!the!cartilage!formed!was!stable,!
did! not! undergo!hypertrophy,! and!did!not! require! preHcommitment!of! neither! cell!
source!in!order!for!chondrogenesis!to!take!place.!!
Before!placing! the!antiHangiogenic! approach! into!practice,! studies! in! an!orthotopic!
environment,! where! cartilage! is! exposed! to! several! physiological! stimuli! such! as!
mechanical!loading,!are!imperative!to!determine!the!longHterm!stability!of!the!newly!
formed!cartilage.!Moreover,!due!to!safety! issues!regarding!the!oncogenic!potential!
of! retroviral! vectors,! the! use! of! selfHinactivating! lentiviral! vectors! for! stable! and!
sustained!transgene!expression!could!be!used!as!an!alternative.!Other!approaches,!




an! antiHangiogenic! approach! in! order! to! trigger! the! initial! chondrogenic! response,!
being! degraded! as! soon! as! the! newly! formed! cartilage! is! in! place! and! angiogenic!
regulation! of! the! cartilage! milieu! is! no! longer! required.! Finally,! once! the!
interdependence! between! chondrogenesis! and! angiogenesis! is! defined,! the!
development!of!“offHtheHshelf”!products,!such!as!biomaterials!capable!of!controlling!
angiogenesis! at! different! stages,! could! trigger! chondrogenesis! at! various!
developmental!stages!depending!on!the!extension!of!the!chondral!damage.!
Several! additional! factors! can! contribute! for! a! successful! cartilage! repair! process.!
Monocyte!and!macrophage!infiltration!at!the!cartilage!lesion!site!can!be!detrimental,!
if!the!inflammatory!process!that!initiates!with!these!cells!is!left!unresolved,!but!it!can!
also! be! highly! beneficial! for! the! new! tissue! being! formed.! Monocytes,! when!




chapter! 3,! by! looking! into! the! phenotype! that! monocytes! acquired! after! being!
directly! or! indirectly! cultured! with! MSC,! a! hybrid! M2HMSCHlike! phenotype! was!
identified;! though! monocytes! under! our! experimental! conditions! do! not! become!
tissueHcompetent! cells,! as! shown! by! their! lack! of! chondrocyte! differentiation!
capacity,! they! may! actively! assist! MSC! in! cartilage! tissue! repair! by! different!
mechanisms,! such! as! the! release! of! soluble! factors! that! may! recruit! MSC! to! the!
lesion!site,!or!by!hampering! the! inflammatory!process! in!order! for! tissue!repair!by!
MSC!to!take!place.!Other!environmental!factors!may!be!added!to!the!culture!in!the!
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future! to! better!mimic! the! cartilage! repair!milieu! in!which!MSC! and! inflammatory!
cells!are!interacting.!
Thus,! understanding! how! MSCHcontrolled! inflammation,! mainly! derived! from!
monocytes,! can! regulate! cartilage! formation! and! repair! may! shed! light! into! new!
therapeutic! approaches! in! cartilage! regeneration.! The! generation! of! biomaterials!
capable!of! polarizing!macrophages! into! a!desired!phenotype! (M2Hlike!or!MSCHlike)!
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